| Symbol | EW |
|---|---|
| Name | EDWARDS LIFESCIENCES CORP |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Orthopedic, Prosthetic & Surgical Appliances & Supplies |
| Address | ONE EDWARDS WAY, IRVINE, CA 92614 |
| Telephone | 9492502500 |
| Fax | — |
| — | |
| Website | https://www.edwards.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001099800 |
| Description | Edwards Lifesciences is the global leader in patient-focused medical innovations for structural heart disease as well as critical care and surgical monitoring. We thrive on discovery and expanding the boundaries of medical technology serving patients in 100+ countries with the help of our employees in areas including Clinical Affairs Quality Engineering Research & Development Regulatory Affairs Sales & Marketing corporate functions and more. Our roots date back to 1958 when Miles Lowell Edwards a retired engineer with a background in hydraulics and fuel pump operations set out to build the first artificial heart. Edwards believed the heart could be mechanized and was encouraged by Dr. Albert Starr to focus on developing an artificial heart valve. After just two years the first Starr-Edwards mitral valve was developed and successfully placed in a patient. This innovation spawned Edwards Laboratories. Additional info from NASDAQ: |
Director Zovighian Bernard J 🟡 adjusted position in 62.5K shares (1 derivative) of Edwards Lifesciences Corp (EW) at $79.96 ($4.9M) Transaction Date: May 11, 2026 | Filing ID: 005172
Read moreBOBO DONALD E JR 🟡 adjusted position in 7.5K shares (1 derivative) of Edwards Lifesciences Corp (EW) at $79.96 Transaction Date: May 11, 2026 | Filing ID: 005171
Read moreChopra Daveen 🟡 adjusted position in 7.5K shares (1 derivative) of Edwards Lifesciences Corp (EW) at $79.96 Transaction Date: May 11, 2026 | Filing ID: 005170
Read more📋 Zovighian Bernard J (Officer) plans to sell 37K shares of Edwards Lifesciences Corp (at $77.94 each, total $2.9M) Filed: May 12, 2026 | ID: 000459
Read moreUllem Scott B. 🟡 adjusted position in 11.0K shares (1 derivative) of Edwards Lifesciences Corp (EW) at $79.96 Transaction Date: May 11, 2026 | Filing ID: 005133
Read moreMarkowitz Wayne 🟡 adjusted position in 35.7K shares (2 derivative) of Edwards Lifesciences Corp (EW) at $83.20 ($2.3M) Transaction Date: May 07, 2026 | Filing ID: 005132
Read moreDirector Zovighian Bernard J 🟡 adjusted position in 323.3K shares (2 derivative) of Edwards Lifesciences Corp (EW) at $83.20 ($21.1M) Transaction Date: May 07, 2026 | Filing ID: 005131
Read moreLippis Daniel J. 🔴 sold 362 shares of Edwards Lifesciences Corp (EW) at $79.96 Transaction Date: May 11, 2026 | Filing ID: 005130
Read more📋 Markowitz Wayne (Officer) plans to sell 593 shares of Edwards Lifesciences Corp (at $79.73 each, total $47K) Filed: May 11, 2026 | ID: 000453
Read moreDirector LORANGER STEVEN R 🟢 acquired 4.3K shares of Edwards Lifesciences Corp (EW) Transaction Date: May 08, 2026 | Filing ID: 005053
Read more| Trial ID | Title | Phase | Indication | Status | Start Date | Completion Date | Source |
|---|---|---|---|---|---|---|---|
| NCT03876964 | J-Valve Compassionate Use | — | Aortic Valve Disease | No_Longer_Available | — | — | ClinicalTrials.gov |
| NCT04902053 | INSPIRIS RESILIA Aortic Valve, Valve-in-Valve Surveillance Study | — | Aortic Valve Replacement | Suspended | 2028-06-01 | 2031-01-01 | ClinicalTrials.gov |
| NCT06167213 | ALLIANCE Mitral: Safety and Effectiveness of SAPIEN X4 Transcatheter Heart Valv… | Na | Mitral Regurgitation | Not_Yet_Recruiting | 2027-01-01 | 2038-03-01 | ClinicalTrials.gov |
| NCT06932640 | Continuous Assessment of Brain Blood Perfusion in Subarachnoid Hemorrhage Patie… | — | Subarachnoid Hemorrhage, Aneurysmal | Not_Yet_Recruiting | 2026-07-01 | 2028-12-01 | ClinicalTrials.gov |
| NCT07363473 | JOURNEY LVAD: JOURNEY Left Ventricular Assist Device | Na | Aortic Valve Regurgitation | Not_Yet_Recruiting | 2026-04-01 | 2029-11-01 | ClinicalTrials.gov |
| NCT07430267 | Dilation Optimisation for Uniform Bioprosthetic Leaflet Expansion | Na | Aortic Stenosis | Not_Yet_Recruiting | 2026-04-01 | 2029-04-01 | ClinicalTrials.gov |
| NCT07216573 | The Continuity Study | Na | Blood Pressure | Recruiting | 2026-04-01 | 2027-02-01 | ClinicalTrials.gov |
| NCT07317648 | ClearSight NextGen1 Study | Na | Blood Pressure | Completed | 2025-10-16 | 2026-03-05 | ClinicalTrials.gov |
| NCT07148323 | HemoSphere Alta Study | — | Hemodynamic Instability | Recruiting | 2025-10-14 | 2026-12-01 | ClinicalTrials.gov |
| NCT07120048 | Real World Data Collection on the INSPIRIS RESILIA Aortic Valve | — | Aortic Valve Disease | Recruiting | 2025-07-30 | 2026-12-01 | ClinicalTrials.gov |
| NCT07059793 | MITRIS China Post Market Clinical Follow-up (PMCF) Study | — | Mitral Valve Replacement | Recruiting | 2025-07-08 | 2038-12-01 | ClinicalTrials.gov |
| NCT05844969 | Circle Method Observational Project - Non-interventional, Retrospective, Multic… | — | Aortic Stenosis With Bicuspid Valve | Not_Yet_Recruiting | 2025-06-01 | 2025-08-01 | ClinicalTrials.gov |
| NCT06991517 | A Study of Transcatheter Aortic Valve Replacement Case Selection and Valve Sizi… | — | Aortic Stenosis | Recruiting | 2025-05-13 | 2027-12-01 | ClinicalTrials.gov |
| NCT06833476 | TTVR STRONG Under Coverage With Evidence Development (CED) Study | — | Tricuspid Regurgitation | Recruiting | 2025-03-19 | 2032-12-31 | ClinicalTrials.gov |
| NCT07058935 | The Asia-Pacific Mitral & Tricuspid Valve-in-Valve/Valve-in-Ring Registry (AP V… | — | Valve Disease, Heart | Recruiting | 2025-03-17 | 2035-12-01 | ClinicalTrials.gov |
| NCT06757049 | Clinical Outcomes of Edwards Lifesciences MITRIS RESLILA Mitral Valve in the As… | — | Mitral Valve Insufficiency | Recruiting | 2024-12-20 | 2031-03-31 | ClinicalTrials.gov |
| NCT06455787 | J-Valve Transfemoral Pivotal Study | Na | Aortic Valve Regurgitation | Recruiting | 2024-10-17 | 2032-02-01 | ClinicalTrials.gov |
| NCT06569602 | Real World European Investigation of Safety and Clinical Efficacy of the EVOQUE… | — | Tricuspid Valve Regurgitation | Recruiting | 2024-10-01 | 2033-09-30 | ClinicalTrials.gov |
| NCT06291714 | Non-invasive Measurement of the Hypotension Prediction Index for the Reduction … | Na | Intraoperative Hypotension | Recruiting | 2024-08-01 | 2026-03-31 | ClinicalTrials.gov |
| NCT06789211 | Outcomes in Moderate Mixed Aortic Valve Disease | — | Mixed Aortic Valve Disease | Recruiting | 2024-06-06 | 2026-12-01 | ClinicalTrials.gov |
| NCT06492746 | Personal BP - CAI Study | Na | Blood Pressure | Recruiting | 2024-06-03 | 2025-12-01 | ClinicalTrials.gov |
| NCT06753227 | Invasive Versus Echocardiography-derived Transvalvular Gradients After TAVI Usi… | — | AORTIC VALVE DISEASES | Enrolling_By_Invitation | 2024-05-28 | 2026-05-31 | ClinicalTrials.gov |
| NCT05906368 | Hypotension Prediction Index to Predict Epidural-labor Analgesia Induced Hypote… | Na | Anesthesia, Epidural | Completed | 2024-04-18 | 2024-08-29 | ClinicalTrials.gov |
| NCT06306729 | Computational Assessment of Bioprosthetic Aortic Valve Function | — | CFD | Unknown | 2024-04-01 | 2026-04-01 | ClinicalTrials.gov |
| NCT06834516 | ClearSight Baby Cuff | — | Blood Pressure | Completed | 2024-01-10 | 2024-03-11 | ClinicalTrials.gov |
| NCT05172973 | ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Va… | Na | Aortic Valve Insufficiency | Recruiting | 2023-11-22 | 2036-02-01 | ClinicalTrials.gov |
| NCT06166719 | Prediction of Complications After Major Gastrointestinal Surgery With Machine L… | — | Surgery-Complications | Unknown | 2023-11-20 | 2026-01-20 | ClinicalTrials.gov |
| NCT06034028 | J-Valve TF Early Feasibility Study | Na | Aortic Valve Disease | Active_Not_Recruiting | 2023-10-16 | 2029-08-25 | ClinicalTrials.gov |
| NCT05601453 | The ReTAVI Prospective Observational Registry | — | Structural Valve Deterioration | Recruiting | 2023-09-05 | 2031-12-01 | ClinicalTrials.gov |
| NCT05750173 | The EASE-IT CT Registry | — | Transcatheter Aortic Valve Implantation (TAVI) | Completed | 2023-09-01 | 2026-03-24 | ClinicalTrials.gov |
| NCT05957406 | SMART TRENDS Study | Na | Moderate to High-risk Noncardiac Surgery | Completed | 2023-07-11 | 2025-10-27 | ClinicalTrials.gov |
| NCT05844774 | Post Anaesthesia Care Hypotension Prevention | Na | Hypotension During Surgery | Unknown | 2023-05-22 | 2024-08-01 | ClinicalTrials.gov |
| NCT06343363 | Early Discharge After Mitral and Tricuspid Edge-to-edge Repair: an Assessment o… | — | Mitral Regurgitation | Completed | 2023-05-01 | 2025-02-11 | ClinicalTrials.gov |
| NCT05686317 | ALT-FLOW II Trial of the Edwards APTURE Transcatheter Shunt System | Na | Heart Failure | Active_Not_Recruiting | 2023-04-01 | 2030-08-31 | ClinicalTrials.gov |
| NCT06040398 | The JUMPSTART Program: Encouraging Early Mobilization and Optimizing Recovery o… | — | Aortic Valve Stenosis | Unknown | 2023-03-01 | 2024-03-31 | ClinicalTrials.gov |
| NCT05760989 | TRISCEND JAPAN Study | Na | Tricuspid Valve Regurgitation | Active_Not_Recruiting | 2023-02-06 | 2029-09-30 | ClinicalTrials.gov |
| NCT05010746 | TVMR With the Innovalve System Trial - Pilot Study in Italy | Na | Mitral Valve Regurgitation (Degenerative or Functional) | Active_Not_Recruiting | 2023-01-24 | 2029-10-04 | ClinicalTrials.gov |
| NCT05526560 | Real-world Clinical Outcomes of the MITRIS RESILIA Mitral Valve | — | Mitral Stenosis | Active_Not_Recruiting | 2023-01-11 | 2035-12-01 | ClinicalTrials.gov |
| NCT05986396 | Outcomes of Pulmonary Valve Replacement With the INSPIRIS (Model 11500A) Valve | — | Heart Valve Prosthesis | Unknown | 2023-01-03 | 2025-12-31 | ClinicalTrials.gov |
| NCT05552352 | VRAP-Heart - Virtual Reality Assisted Patient Empowerment for Interventions in … | Na | Severe Aortic Valve Stenosis | Recruiting | 2022-10-05 | 2027-02-28 | ClinicalTrials.gov |
| NCT05532956 | Evaluation of the Impact of Tricuspid Regurgitation on Patients Lives. Explorat… | — | Severe Tricuspid Regurgitation Medically Treated and Not Operated (Without Valve Replacement or Repair) | Unknown | 2022-09-01 | 2022-10-01 | ClinicalTrials.gov |
| NCT04919980 | TVMR With the INNOVALVE System Trial - Early Feasibility Study | Na | Mitral Valve Regurgitation (Degenerative or Functional) | Recruiting | 2022-09-01 | 2031-07-01 | ClinicalTrials.gov |
| NCT05404880 | INSPIRIS China PMCF Study | — | Aortic Valve Replacement | Active_Not_Recruiting | 2022-07-13 | 2029-12-01 | ClinicalTrials.gov |
| NCT05172960 | ALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve | Na | Aortic Stenosis, Severe | Active_Not_Recruiting | 2022-06-20 | 2034-12-01 | ClinicalTrials.gov |
| NCT05378386 | ALTERRA Post-Approval Study | — | Pulmonary Valve Insufficiency | Active_Not_Recruiting | 2022-05-12 | 2035-07-01 | ClinicalTrials.gov |
| NCT05083403 | HPI (Hypotension Prediction Index) Care Trial | Na | Cardiopulmonary Bypass Surgery | Active_Not_Recruiting | 2022-03-28 | 2025-11-01 | ClinicalTrials.gov |
| NCT05230225 | Electronic Physician Notification to Facilitate the Recognition and Management … | Na | Aortic Stenosis | Unknown | 2022-02-09 | 2026-02-15 | ClinicalTrials.gov |
| NCT05168826 | China S3 PMS: SAPIEN 3 China Post Market Registry Study | — | Aortic Stenosis, Severe | Active_Not_Recruiting | 2022-01-24 | 2035-12-01 | ClinicalTrials.gov |
| NCT03843320 | Impact of SAVR and TAVR on Patient's Activity and Mobility | — | Aortic Valve Stenosis | Suspended | 2021-12-01 | 2024-12-01 | ClinicalTrials.gov |
| NCT05682066 | TVMR With the Innovalve System Trial - Pilot in Georgia | Na | Mitral Valve Regurgitation (Degenerative or Functional) | Completed | 2021-12-01 | 2025-01-01 | ClinicalTrials.gov |
| NCT05105477 | Hypotension Prediction Index (HPI) SMART-BP Trial | Na | Moderate to High-risk Noncardiac Surgery | Terminated | 2021-11-17 | 2022-12-15 | ClinicalTrials.gov |
| NCT04889872 | PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TA… | Na | Aortic Stenosis, Calcific | Recruiting | 2021-10-12 | 2037-06-01 | ClinicalTrials.gov |
| NCT05688514 | TVMR With the Innovalve System Trial - First In Human Israel | Na | Mitral Valve Regurgitation (Degenerative or Functional) | Completed | 2021-10-01 | 2025-04-01 | ClinicalTrials.gov |
| NCT04972266 | The EU Hyprotect Registry | — | Hemodynamic Monitoring | Completed | 2021-09-28 | 2022-09-01 | ClinicalTrials.gov |
| NCT04827238 | Standardized Invasive Hemodynamics for Elevated Gradients Post TAVR (DISCORDANC… | — | Aortic Stenosis | Completed | 2021-08-30 | 2025-06-20 | ClinicalTrials.gov |
| NCT04782154 | Paceport Swan-Ganz Data Collection Study | — | Right Ventricular Dysfunction | Completed | 2021-08-09 | 2022-04-01 | ClinicalTrials.gov |
| NCT05009589 | HUDDLE: Heart Health: Understanding & Diagnosing Disease by Leveraging Echocard… | — | Cardiovascular Diseases | Completed | 2021-07-14 | 2022-10-07 | ClinicalTrials.gov |
| NCT05821647 | Hypotension Prediction 2 Study in Cardiac Surgery and Postoperative ICU Admissi… | Na | Intraoperative Hypotension | Completed | 2021-05-20 | 2023-03-16 | ClinicalTrials.gov |
| NCT04579445 | Setting a Benchmark for Resource Utilization and Quality of Care in Patients Un… | — | Transcatheter Aortic Valve Implantation (TAVI) | Completed | 2021-05-03 | 2024-08-01 | ClinicalTrials.gov |
| NCT04860752 | SAPIEN 3 Ultra EU PMS | — | Aortic Stenosis | Completed | 2021-04-20 | 2024-07-22 | ClinicalTrials.gov |
| NCT04860765 | COMPASSION S3 Post-Approval Study | — | Complex Congenital Heart Defect | Active_Not_Recruiting | 2021-04-13 | 2030-08-01 | ClinicalTrials.gov |
| NCT04482062 | TRISCEND II Pivotal Trial | Na | Tricuspid Valve Regurgitation | Active_Not_Recruiting | 2021-04-09 | 2030-06-27 | ClinicalTrials.gov |
| NCT04807036 | Continuously Iterative Perioperative Holistic Evaluation of Risk and Hypotensio… | — | Surgery--Complications | Not_Yet_Recruiting | 2021-04-01 | 2026-04-01 | ClinicalTrials.gov |
| NCT04965623 | ExplorATory Study oF the EdWards Transcatheter Atrial Shunt System (AlT FloW Ge… | Na | Heart Failure | Withdrawn | 2021-02-22 | 2023-12-06 | ClinicalTrials.gov |
| NCT04614402 | Transcatheter Repair of Tricuspid Regurgitation With Edwards PASCAL Transcathet… | — | Tricuspid Valve Insufficiency | Active_Not_Recruiting | 2021-01-15 | 2028-03-15 | ClinicalTrials.gov |
| NCT04375332 | Beating Heart Mitral Valve Repair With the HARPOON™ System | Na | Mitral Regurgitation | Active_Not_Recruiting | 2020-12-16 | 2027-12-20 | ClinicalTrials.gov |
| NCT04153292 | The ENCIRCLE Trial | Na | Mitral Regurgitation | Recruiting | 2020-11-12 | 2031-02-28 | ClinicalTrials.gov |
| NCT04301102 | The Predict H Trial | Na | Intraoperative Hypotension | Completed | 2020-11-01 | 2022-06-01 | ClinicalTrials.gov |
| NCT04393779 | Observational Registry on the HARPOON Device | Na | Severe Degenerative Mitral Regurgitation Due to Mid-segment Posterior Leaflet Prolapse | Terminated | 2020-10-02 | 2022-11-17 | ClinicalTrials.gov |
| NCT04382612 | Treatment of Mitral Regurgitation Using a Minimally Invasive Approach With the … | Na | Mitral Regurgitation | Terminated | 2020-10-02 | 2022-12-01 | ClinicalTrials.gov |
| NCT04556864 | Hemodynamic Impact on Critical Care Patients With Lung Damage Secondary to COVI… | — | Covid19 | Unknown | 2020-10-01 | 2021-04-01 | ClinicalTrials.gov |
| NCT04585568 | Validation of Ballistocardiographic Biosensors and Other Hemodynamic Measures f… | — | Hemodynamics | Completed | 2020-09-28 | 2020-09-30 | ClinicalTrials.gov |
| NCT04465370 | Pediatric Cardiac Output Monitoring Observational Study | — | Pediatric ALL | Completed | 2020-09-02 | 2023-01-05 | ClinicalTrials.gov |
| NCT04555967 | SAPIEN 3 Ultra System PMCF | — | Aortic Valve Stenosis | Active_Not_Recruiting | 2020-06-30 | 2026-11-01 | ClinicalTrials.gov |
| NCT04151264 | Influence of the "Hypotension Probability Index" on Intraoperative and Postoper… | Na | Hypotension | Completed | 2020-05-30 | 2024-12-01 | ClinicalTrials.gov |
| NCT04221490 | 2019-06 TRISCEND Study | Na | Tricuspid Valve Regurgitation | Active_Not_Recruiting | 2020-05-06 | 2029-01-31 | ClinicalTrials.gov |
| NCT04402931 | Randomized Trial of Transcatheter Valve-in-Valve vs Redo Surgery for Bioprosthe… | Na | Mitral Prosthetic Valve Stenosis and Regurgitation | Completed | 2020-02-17 | 2025-08-01 | ClinicalTrials.gov |
| NCT04755426 | Understanding Patient Goals and Preferences to Facilitate Shared Decision Makin… | — | Aortic Stenosis Symptomatic | Completed | 2020-01-09 | 2022-08-16 | ClinicalTrials.gov |
| NCT04053088 | SAVR: IMPACT of Pre-existing Comorbidities on Patient Outcomes and Prosthetic V… | — | Cardiovascular Diseases | Active_Not_Recruiting | 2019-12-12 | 2026-08-01 | ClinicalTrials.gov |
| NCT04097145 | Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial | Na | Tricuspid Regurgitation | Recruiting | 2019-12-11 | 2031-12-31 | ClinicalTrials.gov |
| NCT04160130 | RHEIA (Randomized researcH in womEn All Comers With Aortic Stenosis) | Na | Aortic Valve Stenosis | Unknown | 2019-11-29 | 2024-06-01 | ClinicalTrials.gov |
| NCT04149314 | The "Hypotension Prediction Index" in Patients Undergoing Lung Surgery | Na | Hypotension | Completed | 2019-11-20 | 2023-10-31 | ClinicalTrials.gov |
| NCT04430075 | MiCLASP Post Market Clinical Follow-Up (PMCF) Study | — | Mitral Regurgitation | Recruiting | 2019-08-23 | 2031-03-31 | ClinicalTrials.gov |
| NCT03779490 | Transcatheter Repair of Tricuspid Regurgitation With Edwards Cardioband TR Syst… | — | Tricuspid Regurgitation | Active_Not_Recruiting | 2019-07-24 | 2027-12-31 | ClinicalTrials.gov |
| NCT04000607 | Exploratory Study of the Edwards APTURE Transcatheter Shunt System (ALT-FLOW Ca… | Na | Heart Failure | Active_Not_Recruiting | 2019-07-10 | 2028-11-11 | ClinicalTrials.gov |
| NCT04443218 | Edwards PASCAL Transcatheter Valve Repair System Registry | — | Mitral Valve Insufficiency | Completed | 2019-05-27 | 2021-05-10 | ClinicalTrials.gov |
| NCT03805217 | Hypotension Prediction Index Study (HPI Study) | — | Hypotension | Completed | 2019-05-16 | 2020-03-17 | ClinicalTrials.gov |
| NCT03666741 | Inspiris Resilia Durability Registry | — | Aortic Valve Stenosis | Active_Not_Recruiting | 2019-04-26 | 2026-07-01 | ClinicalTrials.gov |
| NCT03745313 | Edwards CLASP TR EFS | Na | Tricuspid Regurgitation | Completed | 2019-02-05 | 2025-05-13 | ClinicalTrials.gov |
| NCT04458701 | Prospective Data Analysis of a Quality Improvement Initiative in High Risk Card… | — | Coronary Artery Bypass Graft | Completed | 2019-01-17 | 2020-06-30 | ClinicalTrials.gov |
| NCT03699345 | CENTERA PMCF: Post-Market Follow-up of the CENTERA Transcatheter Heart Valve Sy… | — | Aortic Valve Stenosis | Completed | 2019-01-07 | 2024-08-20 | ClinicalTrials.gov |
| NCT03807622 | ClearSight System CHN Study | — | Patient With Clinically Indicated Invasive Monitoring | Completed | 2018-12-25 | 2019-10-17 | ClinicalTrials.gov |
| NCT03570190 | Registry to Evaluate the Impact of a Valve Coordinator on Aortic Stenosis / TAV… | — | Aortic Valve Stenosis | Completed | 2018-12-20 | 2019-12-19 | ClinicalTrials.gov |
| NCT04092855 | Right Ventricular Pressure Waveform Monitoring in Cardiac Surgery | — | Right Ventricular Dysfunction | Unknown | 2018-12-10 | 2024-12-31 | ClinicalTrials.gov |
| NCT03715894 | Prospective Arm of Conduct - Edwards SAPIEN3 PPI Registry | — | Aortic Valve Stenosis | Completed | 2018-12-01 | 2023-03-30 | ClinicalTrials.gov |
| NCT03706833 | Edwards PASCAL CLASP IID/IIF Pivotal Clinical Trial | Na | Degenerative Mitral Valve Disease | Active_Not_Recruiting | 2018-11-30 | 2031-06-30 | ClinicalTrials.gov |
| NCT03680040 | RESILIENCE Trial: Evaluation of the Durability of Aortic Bioprostheses/Valves W… | — | Aortic Valve Replacement | Terminated | 2018-11-05 | 2024-02-13 | ClinicalTrials.gov |
| NCT03517436 | ExCEED: CENTERA THV System in Intermediate Risk Patients Who Have Symptomatic, … | Na | Aortic Valve Stenosis | Active_Not_Recruiting | 2018-09-18 | 2030-07-01 | ClinicalTrials.gov |
| NCT03454802 | Passive Leg Raising - an Important Diagnostic Manoeuvre | Na | Cardiovascular Insufficiency | Completed | 2018-09-01 | 2020-10-01 | ClinicalTrials.gov |
| NCT03523416 | Early Feasibility Study - Edwards APTURE Transcatheter Shunt System | Na | Heart Failure | Active_Not_Recruiting | 2018-07-31 | 2028-11-01 | ClinicalTrials.gov |
| NCT03382457 | Clinical Study of Edwards Cardioband FIT Valve Repair System | Na | Tricuspid Regurgitation | Active_Not_Recruiting | 2018-07-01 | 2031-12-31 | ClinicalTrials.gov |
| NCT03600688 | Edwards Cardioband European Post-Market Study, MiBAND | — | Mitral Regurgitation | Unknown | 2018-06-06 | 2023-12-31 | ClinicalTrials.gov |
| NCT03471065 | The SAPIEN 3 Ultra System in Intermediate Risk Patients With Symptomatic, Sever… | Na | Aortic Valve Stenosis | Completed | 2018-06-01 | 2025-01-21 | ClinicalTrials.gov |
| NCT03466918 | China S3: Safety and Effectiveness of Edwards Lifesciences SAPIEN 3 THV in the … | Na | Aortic Stenosis | Completed | 2018-05-23 | 2024-06-19 | ClinicalTrials.gov |
| NCT03497611 | Edwards SAPIEN 3 PPI Registry | — | Aortic Valve Stenosis | Completed | 2018-04-30 | 2019-03-03 | ClinicalTrials.gov |
| NCT03469570 | Assisted Fluid Management IDE Study | Na | Non-Cardiac/ Non-Thoracic Surgery | Completed | 2018-04-19 | 2019-01-25 | ClinicalTrials.gov |
| NCT03193801 | PARTNER 3 Trial - Mitral Valve in Valve | Na | Mitral Valve Insufficiency | Active_Not_Recruiting | 2018-02-01 | 2031-08-01 | ClinicalTrials.gov |
| NCT03326778 | Registry to Gather Long-time Results After Surgical Aortic Valve Replacement Wi… | — | Aortic Valve Stenosis | Completed | 2017-11-26 | 2020-07-01 | ClinicalTrials.gov |
| NCT03270124 | A pragmatiC sTrategy to Promote actIVity and Enhance Quality of Life AFTER Tran… | Na | Aortic Valve Stenosis | Completed | 2017-11-07 | 2020-03-25 | ClinicalTrials.gov |
| NCT03314857 | China XT: Safety and Effectiveness of Edwards Lifesciences SAPIEN XT THV in the… | Na | Aortic Stenosis | Completed | 2017-09-18 | 2023-06-15 | ClinicalTrials.gov |
| NCT03230747 | SAPIEN M3 EFS: Early Feasibility Study of the Edwards SAPIEN M3 System for the … | Na | Mitral Regurgitation | Active_Not_Recruiting | 2017-09-14 | 2027-08-01 | ClinicalTrials.gov |
| NCT03250806 | Early Detection of Aortic Stenosis in the Community During Flu Vaccination | — | Aortic Stenosis | Completed | 2017-09-11 | 2017-11-30 | ClinicalTrials.gov |
| NCT03186339 | Validation of the "TASQ" in Patients Undergoing SAVR or TF-TAVI | — | Aortic Valve Stenosis | Completed | 2017-09-08 | 2020-01-13 | ClinicalTrials.gov |
| NCT03130777 | ALTERRA: SAPIEN 3 THV With the Alterra Adaptive Prestent | Na | Pulmonary Disease | Active_Not_Recruiting | 2017-08-22 | 2032-06-01 | ClinicalTrials.gov |
| NCT02987387 | COMPASSION XT PAS - Post-approval Study of the SAPIEN XT THV in Patients With P… | — | Pulmonary Valve Insufficiency | Completed | 2017-07-17 | 2025-09-30 | ClinicalTrials.gov |
| NCT03042104 | EARLY TAVR: Evaluation of TAVR Compared to Surveillance for Patients With Asymp… | Na | Heart Diseases | Active_Not_Recruiting | 2017-07-12 | 2032-03-01 | ClinicalTrials.gov |
| NCT03231956 | CLEAR Sepsis Clinical Study | — | Sepsis | Unknown | 2017-06-29 | 2022-06-30 | ClinicalTrials.gov |
| NCT03170349 | The CLASP Study Edwards PASCAL TrAnScatheter Mitral Valve RePair System Study | Na | Mitral Valve Regurgitation | Completed | 2017-06-27 | 2025-05-27 | ClinicalTrials.gov |
| NCT03016975 | Edwards Cardioband System ACTIVE Pivotal Clinical Trial (ACTIVE) | Na | Functional Mitral Regurgitation | Terminated | 2017-06-01 | 2022-09-20 | ClinicalTrials.gov |
| NCT03285724 | Safety and Performance Study of the Harpoon Mitral Valve Repair System | Na | Mitral Valve Regurgitation | Terminated | 2017-05-16 | 2018-04-20 | ClinicalTrials.gov |
| NCT03088787 | Feasibility of Continuous Noninvasive Finger Arterial Blood Pressure Measuremen… | — | Aortic Stenosis, Calcific | Unknown | 2017-04-01 | 2018-12-01 | ClinicalTrials.gov |
| NCT03112629 | Study to Improve Outcomes in Aortic Stenosis | — | Aortic Valve Stenosis | Completed | 2017-03-23 | 2019-04-03 | ClinicalTrials.gov |
| NCT03795831 | Validation Study in Patients of a Non-invasive Blood Pressure Monitor for Perio… | — | Intraoperative Hypotension | Unknown | 2017-03-01 | 2019-12-30 | ClinicalTrials.gov |
| NCT03003299 | PARTNER 3 Trial - Aortic Valve-in-Valve | Na | Aortic Stenosis | Recruiting | 2017-01-05 | 2038-04-01 | ClinicalTrials.gov |
| NCT02950649 | Evaluation of Clinical Impact of Non-Invasive Hemodynamic Monitoring to Optimiz… | — | Hemodynamic Monitoring | Terminated | 2016-11-17 | 2021-06-14 | ClinicalTrials.gov |
| NCT02830204 | Surgical Implantation of TRAnscatheter vaLve in Native Mitral Annular Calcifica… | Na | Mitral Annular Calcification | Completed | 2016-11-04 | 2023-11-29 | ClinicalTrials.gov |
| NCT02722551 | CardiAQ-Edwards™ Transcatheter Mitral Valve Replacement (TMVR) Study | Phase1 | Mitral Valve Regurgitation | Withdrawn | 2016-11-01 | 2024-10-01 | ClinicalTrials.gov |
| NCT03291925 | Primary Non-invasive Cardiac Computed Tomography Versus Routine Invasive Angiog… | Na | Severe Aortic Stenosis | Unknown | 2016-11-01 | 2019-09-01 | ClinicalTrials.gov |
| NCT02981953 | TRI-REPAIR: TrIcuspid Regurgitation RePAIr With CaRdioband Transcatheter System | Na | Tricuspid Valve Insufficiency | Completed | 2016-10-01 | 2019-11-12 | ClinicalTrials.gov |
| NCT02787408 | The SPACER Trial - Repair of Tricuspid Valve Regurgitation Using the Edwards Tr… | Na | Tricuspid Valve Regurgitation | Completed | 2016-09-14 | 2020-12-14 | ClinicalTrials.gov |
| NCT02964026 | Study of Clinical Outcomes Associated With the Pulmonary Artery Catheter (PAC) … | — | Thoracic Surgery | Completed | 2016-09-01 | 2016-11-01 | ClinicalTrials.gov |
| NCT02903420 | A Clinical Trial of Transcatheter Aortic Valves in Dialysis Patients (Japan) | Na | Aortic Stenosis | Active_Not_Recruiting | 2016-09-01 | 2026-01-01 | ClinicalTrials.gov |
| NCT02703311 | REPAIR - transcatheteR rEPair of mitrAl Insufficiency With caRdioband System | Na | Mitral Valve Insufficiency | Terminated | 2016-08-01 | 2018-12-01 | ClinicalTrials.gov |
| NCT02744677 | COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patient… | Na | Complex Congenital Heart Defect | Recruiting | 2016-07-05 | 2031-06-01 | ClinicalTrials.gov |
| NCT02825134 | Comparison of TAVR With SAVR in Younger Low Surgical Risk Patients With Severe … | Na | Aortic Valve Stenosis | Active_Not_Recruiting | 2016-06-30 | 2029-06-01 | ClinicalTrials.gov |
| NCT02729519 | TAVI Without Balloon Predilatation (of the Aortic Valve ) SAPIEN 3 | Na | Aortic Valve Stenosis | Completed | 2016-06-08 | 2018-08-09 | ClinicalTrials.gov |
| NCT02507557 | Effects of Intraoperative Goal-Directed Fluid Therapy on the Incidence of Posto… | — | Postoperative Complications | Unknown | 2016-05-01 | 2016-12-01 | ClinicalTrials.gov |
| NCT02768870 | CE Mark Study for the Harpoon Medical Device | Na | Mitral Valve Regurgitation | Completed | 2016-04-28 | 2022-09-06 | ClinicalTrials.gov |
| NCT02675114 | PARTNER 3 Trial: Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart V… | Na | Aortic Stenosis | Active_Not_Recruiting | 2016-03-01 | 2029-12-01 | ClinicalTrials.gov |
| NCT02636816 | Cardiovascular Effects of Carbetocin Given During Elective Cesarean | Phase4 | Effect of Carbetocin on Cardiovascular System | Completed | 2016-03-01 | 2016-06-01 | ClinicalTrials.gov |
| NCT02907463 | EDWARDS INTUITY Elite Valve System | — | Aortic Valve Disease | Completed | 2016-02-01 | 2017-12-01 | ClinicalTrials.gov |
| NCT02432196 | CE Mark Study for the Harpoon Medical Device in Poland | Na | Mitral Valve Regurgitation | Completed | 2015-12-11 | 2022-11-16 | ClinicalTrials.gov |
| NCT02656290 | COMMENCE Pulmonary: Clinical Evaluation of Edwards Pericardial Aortic Bioprosth… | Na | Pulmonary Valve Insufficiency | Completed | 2015-12-01 | 2022-11-28 | ClinicalTrials.gov |
| NCT02742974 | Fluid Resuscitation Optimization in Surgical Trauma Patients (FROST) | Na | Critical Illness | Unknown | 2015-12-01 | 2019-12-01 | ClinicalTrials.gov |
| NCT02471807 | Early Feasibility Study of the Edwards FORMA Tricuspid Transcatheter Repair Sys… | Na | Tricuspid Valve Regurgitation | Completed | 2015-12-01 | 2023-01-17 | ClinicalTrials.gov |
| NCT02515539 | Early Feasibility Study of the CardiAQ™ TMVI System (Transfemoral and Transapic… | Na | Mitral Insufficiency | Withdrawn | 2015-08-01 | 2021-07-01 | ClinicalTrials.gov |
| NCT02478008 | A Clinical Study of the CardiAQ™ TMVI System (Transapical DS) | Na | Mitral Insufficiency | Terminated | 2015-06-01 | 2015-08-01 | ClinicalTrials.gov |
| NCT02458560 | CENTERA-2: Safety and Performance Study of the Edwards CENTERA-EU Self-Expandin… | Na | Aortic Valve Disease | Completed | 2015-03-01 | 2021-08-13 | ClinicalTrials.gov |
| NCT02771275 | Safety and Early Feasibility Study of the Harpoon Medical Device (EFS) | Na | Mitral Valve Regurgitation | Completed | 2015-02-15 | 2021-07-16 | ClinicalTrials.gov |
| NCT02718001 | Edwards EVOQUE Eos MISCEND Study | Na | Mitral Valve Regurgitation (Degenerative or Functional) | Active_Not_Recruiting | 2015-02-06 | 2033-04-30 | ClinicalTrials.gov |
| NCT02404467 | Feasibility And Safety of Early Discharge After Transfemoral Transcatheter Aort… | — | Aortic Stenosis | Completed | 2015-01-01 | 2019-07-01 | ClinicalTrials.gov |
| NCT02687035 | PARTNER II Trial: S3iCAP | Na | Aortic Stenosis | Completed | 2015-01-01 | 2018-12-01 | ClinicalTrials.gov |
| NCT02387697 | Treatment of Severe Secondary TRIcuspid Regurgitation in Patients With Advance … | Phase2 | Severe Tricuspid Regurgitation | Terminated | 2015-01-01 | 2018-05-01 | ClinicalTrials.gov |
| NCT02238041 | GlucoClear ICU Study | — | Intensive Care Unit Blood Glucose Monitoring | Withdrawn | 2014-12-01 | 2015-12-01 | ClinicalTrials.gov |
| NCT02523066 | Clinical Study to Evaluate the Performance of Magna Ease Heart Valve in Chinese… | — | Mitral Valve or Aortic Valve Replacement | Terminated | 2014-11-10 | 2025-05-07 | ClinicalTrials.gov |
| NCT02400489 | Clinical Study to Evaluate the Performance of Perimount Heart Valve in Chinese … | — | Mitral Valve or Aortic Valve Replacement | Completed | 2014-09-25 | 2020-06-03 | ClinicalTrials.gov |
| NCT02241447 | Quality of Care in AS IMPULSE Study | — | Aortic Valve Stenosis | Completed | 2014-08-08 | 2018-05-31 | ClinicalTrials.gov |
| NCT02698956 | SOURCE 3: Observational Study to Evaluate Safety and Performance of SAPIEN 3 TH… | — | Aortic Stenosis | Completed | 2014-07-01 | 2020-11-30 | ClinicalTrials.gov |
| NCT03189550 | Enhanced Recovery After Surgery in Colorectal Surgery: A Large-Scale Quality Im… | — | Colorectal Surgery | Completed | 2014-07-01 | 2017-02-17 | ClinicalTrials.gov |
| NCT03047824 | Effects of GlucoClear CGM System on the Performance of Insulin Therapy in Criti… | Na | Metabolic Stress Hyperglycemia | Completed | 2014-05-01 | 2015-06-01 | ClinicalTrials.gov |
| NCT03025971 | Safety & Efficacy of the J-Valve Ausper System in Patients With Severe Aortic S… | Na | Aortic Valve Disease | Completed | 2014-03-01 | 2020-04-01 | ClinicalTrials.gov |
| NCT03222128 | PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - S3 Intermediate | Na | Symptomatic Severe Aortic Stenosis | Completed | 2014-02-17 | 2024-10-09 | ClinicalTrials.gov |
| NCT03222141 | PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - High Risk and N… | Na | Symptomatic Severe Aortic Stenosis | Completed | 2013-10-01 | 2020-08-01 | ClinicalTrials.gov |
| NCT02094859 | GlucoClearTM System ICU Study | — | Accurate Blood Glucose Monitoring in Critical Care Setting | Completed | 2013-04-01 | 2013-09-01 | ClinicalTrials.gov |
| NCT01808274 | Safety and Performance Study of the Edwards CENTERA Self-Expanding Transcathete… | Na | Aortic Valve Disease | Completed | 2013-02-01 | 2018-08-23 | ClinicalTrials.gov |
| NCT01808287 | Safety and Performance Study of the Edwards SAPIEN 3 Transcatheter Heart Valve/… | Na | Aortic Valve Disease | Completed | 2013-01-01 | 2019-12-17 | ClinicalTrials.gov |
| NCT01757665 | ProspeCtive, nOn-randoMized, MulticENter Clinical Evaluation of Edwards Pericar… | Na | Aortic Stenosis | Active_Not_Recruiting | 2012-12-11 | 2026-08-01 | ClinicalTrials.gov |
| NCT01753050 | HIP Surgery - Hemodynamic Optimization Project | Na | Redo Hip Surgery | Unknown | 2012-12-01 | 2019-12-01 | ClinicalTrials.gov |
| NCT02688153 | EDWARDS INTUITY Valve System CADENCE Study | Na | Aortic Valve Disease | Completed | 2012-10-01 | 2016-04-01 | ClinicalTrials.gov |
| NCT01700439 | Surgical Treatment of Aortic Stenosis With a Next Generation, Rapid Deployment … | Na | Aortic Valve Stenosis | Completed | 2012-09-26 | 2021-05-26 | ClinicalTrials.gov |
| NCT02338154 | EDWARDS INTUITY Valve System FOUNDATION Study | — | Aortic Valve Disease | Completed | 2012-07-01 | 2016-04-01 | ClinicalTrials.gov |
| NCT03225001 | PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - Nested Registry… | Na | Aortic Stenosis | Completed | 2012-06-11 | 2020-10-28 | ClinicalTrials.gov |
| NCT01617720 | MITRAFIT- Cardinal Adjustable Mitral Repair Follow-up International Postmarketi… | — | Mitral Regurgitation | Completed | 2012-05-01 | 2016-06-01 | ClinicalTrials.gov |
| NCT02672553 | EDWARDS INTUITY Valve System CADENCE-MIS Study | Na | Aortic Valve Disease | Completed | 2012-05-01 | 2015-08-01 | ClinicalTrials.gov |
| NCT01675596 | The SOLACE-AU Clinical Trial | Na | Severe, Symptomatic Aortic Stenosis | Completed | 2012-04-01 | 2018-08-08 | ClinicalTrials.gov |
| NCT01559298 | Aspirin Versus Aspirin + ClopidogRel Following Transcatheter Aortic Valve Impla… | Phase4 | Aortic Valve Disease | Completed | 2012-03-01 | 2016-03-01 | ClinicalTrials.gov |
| NCT01522352 | Comparison Between Three Types of Stented Pericardial Aortic Valves | Na | Aortic Valve Replacement | Unknown | 2012-03-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT01519050 | Predictors of Postoperative Left Ventricular Function in Patients Undergoing Mi… | — | Severe Degenerative Mitral Regurgitation | Unknown | 2011-11-01 | 2014-05-01 | ClinicalTrials.gov |
| NCT01841554 | Cardioband With Transfemoral Delivery System | Na | Mitral Regurgitation | Completed | 2011-09-01 | 2018-06-01 | ClinicalTrials.gov |
| NCT01651052 | Clinical Trial of the Edwards Aortic Bioprosthesis, Model 11000 | Na | Aortic Valve Disorder | Completed | 2011-07-01 | 2018-07-01 | ClinicalTrials.gov |
| NCT01419015 | PREVAIL-20J - Transfemoral Placement of 20mm Aortic Balloon Expandable Transcat… | Na | Aortic Valve Stenosis | Completed | 2011-06-01 | 2017-12-01 | ClinicalTrials.gov |
| NCT02184442 | The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves - PII B | Na | Severe | Completed | 2011-03-09 | 2017-05-30 | ClinicalTrials.gov |
| NCT01314313 | PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - XT Intermediate… | Na | Symptomatic Severe Aortic Stenosis | Completed | 2011-03-01 | 2024-01-17 | ClinicalTrials.gov |
| NCT01312779 | Magna Mitral - 23mm | Na | Mitral Heart Valve Disease | Completed | 2011-03-01 | 2018-11-01 | ClinicalTrials.gov |
| NCT01356108 | Pulmonic Valve REplacement Multi-discIpline EMEA Registry | — | Pulmonary Regurgitation | Completed | 2011-01-01 | 2017-12-19 | ClinicalTrials.gov |
| NCT01415947 | V-Chordal Adjustable System for Chordal Replacement in Mitral Valve Insufficien… | Phase2 | Mitral Leaflet Prolapse | Terminated | 2010-11-01 | 2013-03-01 | ClinicalTrials.gov |
| NCT01238497 | SOURCE XT REGISTRY | — | Severe Aortic Stenosis | Completed | 2010-09-01 | 2016-11-01 | ClinicalTrials.gov |
| NCT01246947 | Tricuspid Annuloplasty for Moderate Tricuspid Regurgitation Associated With Mir… | Na | Cardiac Surgery | Completed | 2010-09-01 | 2017-02-01 | ClinicalTrials.gov |
| NCT01208077 | PREMIUM Registry: PRognostic HEModynamIc Profiling in the AcUtely Ill EMergency… | — | Acute CHF | Completed | 2010-09-01 | 2012-09-01 | ClinicalTrials.gov |
| NCT01113983 | PREVAIL-J - Transfemoral & Transapical Placement of Aortic Balloon Expandable T… | Na | Aortic Valve Stenosis | Completed | 2010-04-01 | 2016-05-01 | ClinicalTrials.gov |
| NCT01137734 | CARDINAL Adjustable Annuloplasty Ring System For Treatment of Mitral Regurgitat… | Na | Mitral Valve Insufficiency | Completed | 2010-03-01 | 2014-01-01 | ClinicalTrials.gov |
| NCT01405040 | Clinical Evaluation of a New Transpulmonary Thermodilution Method to Assess The… | — | Cardiac Output and Preload Assessment | Completed | 2010-01-01 | 2010-12-01 | ClinicalTrials.gov |
| NCT01445171 | Surgical Treatment of Aortic Stenosis With a Next Generation Surgical Aortic Va… | Na | Aortic Valve Stenosis With Insufficiency | Completed | 2010-01-01 | 2017-12-01 | ClinicalTrials.gov |
| NCT01238835 | PREVAIL-TA: Placement of Aortic Balloon Expandable Transcatheter Valves Trial (… | Na | Aortic Valve Stenosis | Completed | 2009-09-01 | 2016-03-01 | ClinicalTrials.gov |
| NCT00906490 | Clinical Study of the Intravenous Blood Glucose System in Hospitalized Adult El… | — | Blood Glucose | Completed | 2009-06-01 | 2010-05-01 | ClinicalTrials.gov |
| NCT00820599 | PREVAIL-TF: Transfemoral Placement of Aortic Balloon Expandable Transcatheter V… | Na | Aortic Valve Stenosis | Completed | 2008-12-01 | 2016-03-01 | ClinicalTrials.gov |
| NCT00676689 | COMPASSION - COngenital Multicenter Trial of Pulmonic VAlve Regurgitation Study… | Na | Pulmonary Valve Insufficiency | Completed | 2008-04-08 | 2019-12-31 | ClinicalTrials.gov |
| NCT00631683 | Assessment of Hemodynamic Changes During Weaning From Mechanical Ventilation Wi… | — | Mechanical Ventilation | Withdrawn | 2008-02-01 | 2008-02-01 | ClinicalTrials.gov |
| NCT00583687 | Pulse Contour Analysis and Tissue Oxymetry in Changing Vascular Tone | Na | Cardiac Output, High | Completed | 2007-12-01 | 2009-01-01 | ClinicalTrials.gov |
| NCT01171625 | Carpentier-Edwards PERIMOUNT Magna Ease Pericardial Bioprosthesis, Model 3300TFX | Na | Coronary Artery Disease | Completed | 2007-10-01 | 2018-09-01 | ClinicalTrials.gov |
| NCT00853632 | Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol | Na | Coronary Artery Disease | Completed | 2007-08-01 | 2024-03-06 | ClinicalTrials.gov |
| NCT00526331 | Evaluation of Arterial Pressure Based Cardiac Output for Goal-Directed Perioper… | Phase4 | Esophageal Diseases | Completed | 2007-08-01 | 2008-09-01 | ClinicalTrials.gov |
| NCT00530894 | THE PARTNER TRIAL: Placement of AoRTic TraNscathetER Valve Trial | Na | Critical Aortic Stenosis | Completed | 2007-04-01 | 2017-07-01 | ClinicalTrials.gov |
| NCT00465218 | Transcranial Doppler (TCD) Assessment During Early Anti-thrombotic Therapy Afte… | — | Aortic Valve Disease | Completed | 2007-03-01 | 2011-03-01 | ClinicalTrials.gov |
| NCT00428103 | Effects of Mitral Valve Repair With the Geoform Ring on Cardiomyopathy | Na | Mitral Valve Regurgitation | Withdrawn | 2006-10-01 | 2012-12-01 | ClinicalTrials.gov |
| NCT00354211 | Using Minimally Invasive Cardiac Output Data vs. Standard Care for Patients Eme… | — | Cardiac Output, High | Completed | 2006-07-01 | 2007-12-01 | ClinicalTrials.gov |
| Product Name | Type | Development Stage | Therapeutic Area | Study Status | Trial ID |
|---|---|---|---|---|---|
| Inspectra TM/O-To-See TM (Tissue oxymetry with near infrared spectroscopy and laser-Doppler) | Other | Approved | Cardiac Output, High | COMPLETED | NCT00583687 |
| Volume challenge / Change of vasoactive drugs or inotropics | Drug | Approved | Cardiac Output, High | COMPLETED | NCT00583687 |
| Passive leg raising | Other | Approved | Cardiac Output, High | COMPLETED | NCT00583687 |
| Vigileo TM / Flotrac TM (Minimally invasive cardiac output system consisting of arterial line sensor and cardiac output monitor) | Other | Approved | Cardiac Output, High | COMPLETED | NCT00583687 |
| Inspectra TM/O-To-See TM (Tissue oxymetry with near infrared spectroscopy and laser-Doppler) | Other | Approved | Cardiac Output, High | COMPLETED | NCT00583687 |
| Volume challenge / Change of vasoactive drugs or inotropics | Drug | Approved | Cardiac Output, High | COMPLETED | NCT00583687 |
| Passive leg raising | Other | Approved | Cardiac Output, High | COMPLETED | NCT00583687 |
| Vigileo TM / Flotrac TM (Minimally invasive cardiac output system consisting of arterial line sensor and cardiac output monitor) | Other | Approved | Cardiac Output, High | COMPLETED | NCT00583687 |
| FloTrac Sensor | Other | Phase PHASE4 | Esophageal Diseases | COMPLETED | NCT00526331 |
| Vigileo Monitor | Other | Phase PHASE4 | Esophageal Diseases | COMPLETED | NCT00526331 |
| FloTrac Sensor | Other | Phase PHASE4 | Esophageal Diseases | COMPLETED | NCT00526331 |
| Vigileo Monitor | Other | Phase PHASE4 | Esophageal Diseases | COMPLETED | NCT00526331 |
| FloTrac Sensor | Other | Phase PHASE4 | Esophageal Diseases | COMPLETED | NCT00526331 |
| Vigileo Monitor | Other | Phase PHASE4 | Esophageal Diseases | COMPLETED | NCT00526331 |
| mitral valve repair | Other | Preclinical | Severe Degenerative Mitral Regurgitation | UNKNOWN | NCT01519050 |
| mitral valve repair | Other | Preclinical | Severe Degenerative Mitral Regurgitation | UNKNOWN | NCT01519050 |
| mitral valve repair | Other | Preclinical | Severe Degenerative Mitral Regurgitation | UNKNOWN | NCT01519050 |
| Prophylaxis of Thrombosis after aortic valve replacement | Other | Preclinical | Aortic Valve Disease | COMPLETED | NCT00465218 |
| minimally invasive cardiac output system consisting of arterial line sensor and cardiac output bedside monitor (device) | Device | Preclinical | Cardiac Output, High | COMPLETED | NCT00354211 |
| 3 dimensional echocardiography | Other | Approved | Mitral Valve Regurgitation | WITHDRAWN | NCT00428103 |
| 3 dimensional echocardiography | Other | Approved | Mitral Valve Regurgitation | WITHDRAWN | NCT00428103 |
| Aortic valve replacement by bioprosthesis | Other | Approved | Aortic Valve Replacement | UNKNOWN | NCT01522352 |
| V Chordal | Other | Phase PHASE2 | Mitral Leaflet Prolapse | TERMINATED | NCT01415947 |
| Heart Valve Surgery | Procedure | Approved | Aortic Valve Disorder | COMPLETED | NCT01651052 |
| EV1000NI Clinical Platform: Noninvasive Hemodynamic Monitoring utilizing ClearSight System | Other | Preclinical | Patient With Clinically Indicated Invasive Monitoring | COMPLETED | NCT03807622 |
| TF TAVI | Other | Preclinical | Aortic Stenosis | COMPLETED | NCT02404467 |
| SAPIEN XT™ Transapical aortic valve replacement | Other | Approved | Aortic Valve Stenosis | COMPLETED | NCT01238835 |
| SAPIEN XT™ Transapical aortic valve replacement | Other | Approved | Aortic Valve Stenosis | COMPLETED | NCT01238835 |
| JUMPSTART exercise program | Other | Preclinical | Aortic Valve Stenosis | RECRUITING | NCT06040398 |
| V Chordal | Other | Phase PHASE2 | Mitral Leaflet Prolapse | TERMINATED | NCT01415947 |
| GlucoClear System | Other | Preclinical | Intensive Care Unit Blood Glucose Monitoring | WITHDRAWN | NCT02238041 |
| GlucoClear System | Other | Preclinical | Intensive Care Unit Blood Glucose Monitoring | WITHDRAWN | NCT02238041 |
| GlucoClear System | Other | Preclinical | Intensive Care Unit Blood Glucose Monitoring | WITHDRAWN | NCT02238041 |
| CardiAQ TMVI System (Transapical & Transfemoral DS) | Other | Approved | Mitral Insufficiency | WITHDRAWN | NCT02515539 |
| CardiAQ TMVI System (Transapical & Transfemoral DS) | Other | Approved | Mitral Insufficiency | WITHDRAWN | NCT02515539 |
| CardiAQ TMVI System (Transapical DS) | Other | Approved | Mitral Insufficiency | TERMINATED | NCT02478008 |
| CardiAQ TMVI System (Transapical DS) | Other | Approved | Mitral Insufficiency | TERMINATED | NCT02478008 |
| FloTrac™ and EV1000™ | Other | Approved | Critical Illness | UNKNOWN | NCT02742974 |
| FloTrac™ and EV1000™ | Other | Approved | Critical Illness | UNKNOWN | NCT02742974 |
| carbetocin | Other | Phase PHASE4 | Effect of Carbetocin on Cardiovascular System | COMPLETED | NCT02636816 |
| carbetocin | Other | Phase PHASE4 | Effect of Carbetocin on Cardiovascular System | COMPLETED | NCT02636816 |
| pulmonary artery catheter | Other | Preclinical | Thoracic Surgery | COMPLETED | NCT02964026 |
| pulmonary artery catheter | Other | Preclinical | Thoracic Surgery | COMPLETED | NCT02964026 |
| pulmonary artery catheter | Other | Preclinical | Thoracic Surgery | COMPLETED | NCT02964026 |
| Standard of care | Other | Approved | Metabolic Stress Hyperglycemia | COMPLETED | NCT03047824 |
| Intravascular continuous monitoring | Other | Approved | Metabolic Stress Hyperglycemia | COMPLETED | NCT03047824 |
| Standard of care | Other | Approved | Metabolic Stress Hyperglycemia | COMPLETED | NCT03047824 |
| Intravascular continuous monitoring | Other | Approved | Metabolic Stress Hyperglycemia | COMPLETED | NCT03047824 |
| medical management and/or balloon aortic valvuloplasty | Other | Approved | Critical Aortic Stenosis | COMPLETED | NCT00530894 |
| Surgical Valve Replacement | Other | Approved | Critical Aortic Stenosis | COMPLETED | NCT00530894 |
| Edwards SAPIEN Transcatheter Heart Valve | Other | Approved | Critical Aortic Stenosis | COMPLETED | NCT00530894 |
| medical management and/or balloon aortic valvuloplasty | Other | Approved | Critical Aortic Stenosis | COMPLETED | NCT00530894 |
| Surgical Valve Replacement | Other | Approved | Critical Aortic Stenosis | COMPLETED | NCT00530894 |
| Edwards SAPIEN Transcatheter Heart Valve | Other | Approved | Critical Aortic Stenosis | COMPLETED | NCT00530894 |
| Procedure/Surgery: Invasive angiography | Procedure | Approved | Severe Aortic Stenosis | UNKNOWN | NCT03291925 |
| Selective invasive angiography based on CT/CCTA imaging. | Other | Approved | Severe Aortic Stenosis | UNKNOWN | NCT03291925 |
| Procedure/Surgery: Invasive angiography | Procedure | Approved | Severe Aortic Stenosis | UNKNOWN | NCT03291925 |
| Selective invasive angiography based on CT/CCTA imaging. | Other | Approved | Severe Aortic Stenosis | UNKNOWN | NCT03291925 |
| Transcatheter Mitral Valve Re-placement (TMVR) with the CardiAQ-Edwards™ Transcatheter Mitral Valve | Other | Phase PHASE1 | Mitral Valve Regurgitation | WITHDRAWN | NCT02722551 |
| Transcatheter Mitral Valve Re-placement (TMVR) with the CardiAQ-Edwards™ Transcatheter Mitral Valve | Other | Phase PHASE1 | Mitral Valve Regurgitation | WITHDRAWN | NCT02722551 |
| Nexfin measuremtents | Other | Preclinical | Aortic Stenosis, Calcific | UNKNOWN | NCT03088787 |
| Stented aortic bioprostheses | Other | Approved | Aortic Valve Disease | COMPLETED | NCT02688153 |
| EDWARDS INTUITY | Other | Approved | Aortic Valve Disease | COMPLETED | NCT02688153 |
| Stented aortic bioprostheses | Other | Approved | Aortic Valve Disease | COMPLETED | NCT02688153 |
| EDWARDS INTUITY | Other | Approved | Aortic Valve Disease | COMPLETED | NCT02688153 |
| Edwards Sapien XT Valve | Other | Phase PHASE2 | Severe Tricuspid Regurgitation | TERMINATED | NCT02387697 |
| Edwards CENTERA Self-Expanding Transcatheter Heart Valve | Other | Approved | Aortic Valve Disease | COMPLETED | NCT01808274 |
| Edwards CENTERA Self-Expanding Transcatheter Heart Valve | Other | Approved | Aortic Valve Disease | COMPLETED | NCT01808274 |
| Transcatheter Pulmonic Valve Replacement (TPVR) (Edwards SAPIEN™ THV) | Other | Preclinical | Pulmonary Regurgitation | COMPLETED | NCT01356108 |
| Transcatheter Pulmonic Valve Replacement (TPVR) (Edwards SAPIEN™ THV) | Other | Preclinical | Pulmonary Regurgitation | COMPLETED | NCT01356108 |
| Transcatheter Pulmonic Valve Replacement (TPVR) (Edwards SAPIEN™ THV) | Other | Preclinical | Pulmonary Regurgitation | COMPLETED | NCT01356108 |
| ClearSight feasibility testing | Other | Preclinical | Intraoperative Hypotension | UNKNOWN | NCT03795831 |
| ClearSight feasibility testing | Other | Preclinical | Intraoperative Hypotension | UNKNOWN | NCT03795831 |
| ClearSight feasibility testing | Other | Preclinical | Intraoperative Hypotension | UNKNOWN | NCT03795831 |
| Stented Aortic Bioprostheses | Other | Approved | Aortic Valve Disease | COMPLETED | NCT02672553 |
| EDWARDS INTUITY Valve System, Model 8300A | Other | Approved | Aortic Valve Disease | COMPLETED | NCT02672553 |
| Stented Aortic Bioprostheses | Other | Approved | Aortic Valve Disease | COMPLETED | NCT02672553 |
| EDWARDS INTUITY Valve System, Model 8300A | Other | Approved | Aortic Valve Disease | COMPLETED | NCT02672553 |
| Noninvasive hemodynamic monitoring | Other | Preclinical | Colorectal Surgery | COMPLETED | NCT03189550 |
| Standard perioperative care | Other | Preclinical | Colorectal Surgery | COMPLETED | NCT03189550 |
| ERAS perioperative care | Other | Preclinical | Colorectal Surgery | COMPLETED | NCT03189550 |
| Noninvasive hemodynamic monitoring | Other | Preclinical | Colorectal Surgery | COMPLETED | NCT03189550 |
| Standard perioperative care | Other | Preclinical | Colorectal Surgery | COMPLETED | NCT03189550 |
| ERAS perioperative care | Other | Preclinical | Colorectal Surgery | COMPLETED | NCT03189550 |
| TAVR Implantation of the Transcatheter Aortic Valve Prosthesis | Other | Approved | Severe, Symptomatic Aortic Stenosis | COMPLETED | NCT01675596 |
| Stroke volume monitoring | Other | Approved | Redo Hip Surgery | UNKNOWN | NCT01753050 |
| Stroke volume monitoring | Other | Approved | Redo Hip Surgery | UNKNOWN | NCT01753050 |
| Harpoon Artificial ePTFE Chords | Other | Approved | Mitral Valve Regurgitation | TERMINATED | NCT03285724 |
| Harpoon Artificial ePTFE Chords | Other | Approved | Mitral Valve Regurgitation | TERMINATED | NCT03285724 |
| SAPIEN Transcatheter Valve Implantation | Other | Approved | Pulmonary Valve Insufficiency | COMPLETED | NCT00676689 |
| SAPIEN Transcatheter Valve Implantation | Other | Approved | Pulmonary Valve Insufficiency | COMPLETED | NCT00676689 |
| ClearSight™ / EV1000NI Clinical Platform | Other | Preclinical | Sepsis | UNKNOWN | NCT03231956 |
| ClearSight™ / EV1000NI Clinical Platform | Other | Preclinical | Sepsis | UNKNOWN | NCT03231956 |
| ClearSight™ / EV1000NI Clinical Platform | Other | Preclinical | Sepsis | UNKNOWN | NCT03231956 |
| Implantation of CEP Magna Mitral Model 7000TFX | Other | Approved | Mitral Heart Valve Disease | COMPLETED | NCT01312779 |
| Implantation of CEP Magna Mitral Model 7000TFX | Other | Approved | Mitral Heart Valve Disease | COMPLETED | NCT01312779 |
| Implantation of CEP Magna Mitral Model 7000TFX | Other | Approved | Mitral Heart Valve Disease | COMPLETED | NCT01312779 |
| Edwards SAPIEN 3 Transcatheter Heart Valve | Other | Approved | Aortic Valve Disease | COMPLETED | NCT01808287 |
| Edwards SAPIEN 3 Transcatheter Heart Valve | Other | Approved | Aortic Valve Disease | COMPLETED | NCT01808287 |
| Implantation of CEP Magna Ease Model 3300TFX | Other | Approved | Coronary Artery Disease | COMPLETED | NCT01171625 |
| Implantation of CEP Magna Ease Model 3300TFX | Other | Approved | Coronary Artery Disease | COMPLETED | NCT01171625 |
| Transcatheter aortic valve implantation | Other | Approved | Aortic Valve Stenosis | COMPLETED | NCT01113983 |
| Transcatheter aortic valve implantation | Other | Approved | Aortic Valve Stenosis | COMPLETED | NCT01113983 |
| SAPIEN XT NovaFlex delivery system | Other | Approved | Aortic Valve Stenosis | COMPLETED | NCT01419015 |
| SAPIEN XT NovaFlex delivery system | Other | Approved | Aortic Valve Stenosis | COMPLETED | NCT01419015 |
| TAVR Implantation of the Transcatheter Aortic Valve Prosthesis | Other | Preclinical | Severe Aortic Stenosis | COMPLETED | NCT01238497 |
| TAVR Implantation of the Transcatheter Aortic Valve Prosthesis | Other | Preclinical | Severe Aortic Stenosis | COMPLETED | NCT01238497 |
| Hemodynamic monitoring | Other | Preclinical | Coronary Artery Bypass Graft | COMPLETED | NCT04458701 |
| Hemodynamic monitoring | Other | Preclinical | Coronary Artery Bypass Graft | COMPLETED | NCT04458701 |
| transcatheter valve implantation | Other | Preclinical | Aortic Valve Stenosis | COMPLETED | NCT03497611 |
| transcatheter valve implantation | Other | Preclinical | Aortic Valve Stenosis | COMPLETED | NCT03497611 |
| transcatheter valve implantation | Other | Preclinical | Aortic Valve Stenosis | COMPLETED | NCT03497611 |
| Biosensors | Other | Preclinical | Hemodynamics | COMPLETED | NCT04585568 |
| Sapien XT™ transcatheter heart valve and delivery system | Other | Approved | Aortic Valve Stenosis | COMPLETED | NCT00820599 |
| Sapien XT™ transcatheter heart valve and delivery system | Other | Approved | Aortic Valve Stenosis | COMPLETED | NCT00820599 |
| Cardioband | Other | Approved | Mitral Valve Insufficiency | TERMINATED | NCT02703311 |
| Cardioband | Other | Approved | Mitral Valve Insufficiency | TERMINATED | NCT02703311 |
| Cardioband | Other | Approved | Mitral Regurgitation | COMPLETED | NCT01841554 |
| Cardioband | Other | Approved | Mitral Regurgitation | COMPLETED | NCT01841554 |
| Carpentier-Edwards PERIMOUNT Magna-Ease | Other | Preclinical | Aortic Valve Stenosis | SUSPENDED | NCT03843320 |
| EDWARDS INTUITY | Other | Preclinical | Aortic Valve Stenosis | SUSPENDED | NCT03843320 |
| INSPIRIS RESILIA | Other | Preclinical | Aortic Valve Stenosis | SUSPENDED | NCT03843320 |
| SAPIEN XT | Other | Preclinical | Aortic Valve Stenosis | SUSPENDED | NCT03843320 |
| SAPIEN 3 | Other | Preclinical | Aortic Valve Stenosis | SUSPENDED | NCT03843320 |
| Carpentier-Edwards PERIMOUNT Magna-Ease | Other | Preclinical | Aortic Valve Stenosis | SUSPENDED | NCT03843320 |
| EDWARDS INTUITY | Other | Preclinical | Aortic Valve Stenosis | SUSPENDED | NCT03843320 |
| INSPIRIS RESILIA | Other | Preclinical | Aortic Valve Stenosis | SUSPENDED | NCT03843320 |
| SAPIEN XT | Other | Preclinical | Aortic Valve Stenosis | SUSPENDED | NCT03843320 |
| SAPIEN 3 | Other | Preclinical | Aortic Valve Stenosis | SUSPENDED | NCT03843320 |
| Edwards SAPIEN XT transcatheter valve, Model 9300TFX | Other | Approved | Aortic Stenosis | COMPLETED | NCT03225001 |
| Edwards SAPIEN XT transcatheter valve, Model 9300TFX | Other | Approved | Aortic Stenosis | COMPLETED | NCT03225001 |
| TAVI (Transcatheter Aortic Valve Implantation) | Other | Preclinical | Aortic Stenosis | COMPLETED | NCT02698956 |
| Hypotension Prediction Index | Other | Preclinical | Surgery--Complications | NOT_YET_RECRUITING | NCT04807036 |
| Hypotension Prediction Index | Other | Preclinical | Surgery--Complications | NOT_YET_RECRUITING | NCT04807036 |
| Daily Activity Recording | Other | Approved | Aortic Valve Stenosis | COMPLETED | NCT03270124 |
| Resistance Exercises | Other | Approved | Aortic Valve Stenosis | COMPLETED | NCT03270124 |
| Daily Activity Goal | Other | Approved | Aortic Valve Stenosis | COMPLETED | NCT03270124 |
| Daily Activity Recording | Other | Approved | Aortic Valve Stenosis | COMPLETED | NCT03270124 |
| Resistance Exercises | Other | Approved | Aortic Valve Stenosis | COMPLETED | NCT03270124 |
| Daily Activity Goal | Other | Approved | Aortic Valve Stenosis | COMPLETED | NCT03270124 |
| SAPIEN S3 valve | Other | Approved | Aortic Stenosis | COMPLETED | NCT02687035 |
| SAPIEN S3 valve | Other | Approved | Aortic Stenosis | COMPLETED | NCT02687035 |
| TAVR Implantation of the THV Prosthesis | Other | Approved | Symptomatic Severe Aortic Stenosis | COMPLETED | NCT03222141 |
| Cardioband Tricuspid | Other | Approved | Tricuspid Valve Insufficiency | COMPLETED | NCT02981953 |
| Cardioband Tricuspid | Other | Approved | Tricuspid Valve Insufficiency | COMPLETED | NCT02981953 |
| AVR and CABG | Other | Preclinical | Aortic Valve Stenosis | COMPLETED | NCT03326778 |
| AVR and CABG | Other | Preclinical | Aortic Valve Stenosis | COMPLETED | NCT03326778 |
| Passive Leg Raising | Other | Approved | Cardiovascular Insufficiency | COMPLETED | NCT03454802 |
| Passive Leg Raising | Other | Approved | Cardiovascular Insufficiency | COMPLETED | NCT03454802 |
| Edwards CENTERA Self-Expanding Transcatheter Heart Valve | Other | Approved | Aortic Valve Disease | COMPLETED | NCT02458560 |
| Edwards CENTERA Self-Expanding Transcatheter Heart Valve | Other | Approved | Aortic Valve Disease | COMPLETED | NCT02458560 |
| Edwards CENTERA Self-Expanding Transcatheter Heart Valve | Other | Approved | Aortic Valve Disease | COMPLETED | NCT02458560 |
| Device: Adjustable Annuloplasty Ring (with option to adjust off-pump) | Device | Approved | Mitral Valve Insufficiency | COMPLETED | NCT01137734 |
| Adjustable Annuloplasty Ring with option to adjust off pump. | Other | Approved | Mitral Valve Insufficiency | COMPLETED | NCT01137734 |
| Physician Notification Letter | Other | Approved | Aortic Stenosis | UNKNOWN | NCT05230225 |
| Physician Notification Letter | Other | Approved | Aortic Stenosis | RECRUITING | NCT05230225 |
| Physician Notification Letter | Other | Approved | Aortic Stenosis | UNKNOWN | NCT05230225 |
| No Hemodynamic Monitored Guided Assesment | Other | Preclinical | Hemodynamic Monitoring | TERMINATED | NCT02950649 |
| invasive Hemodynamic monitoring via Clearsight/Nexfin Systems from Edwards Lifesciences | Other | Preclinical | Hemodynamic Monitoring | TERMINATED | NCT02950649 |
| No Hemodynamic Monitored Guided Assesment | Other | Preclinical | Hemodynamic Monitoring | TERMINATED | NCT02950649 |
| invasive Hemodynamic monitoring via Clearsight/Nexfin Systems from Edwards Lifesciences | Other | Preclinical | Hemodynamic Monitoring | TERMINATED | NCT02950649 |
| Coordinator | Other | Preclinical | Aortic Valve Stenosis | COMPLETED | NCT03570190 |
| SAVR | Other | Preclinical | Aortic Valve Stenosis | COMPLETED | NCT03186339 |
| TAVI | Other | Preclinical | Aortic Valve Stenosis | COMPLETED | NCT03186339 |
| EW Tricuspid Transcatheter Repair System | Other | Approved | Tricuspid Valve Regurgitation | COMPLETED | NCT02787408 |
| EW Tricuspid Transcatheter Repair System | Other | Approved | Tricuspid Valve Regurgitation | COMPLETED | NCT02787408 |
| EW Tricuspid Transcatheter Repair System | Other | Approved | Tricuspid Valve Regurgitation | COMPLETED | NCT02787408 |
| AVITA--Aortic Valve Improved Treatment Approaches | Drug | Preclinical | Aortic Stenosis Symptomatic | COMPLETED | NCT04755426 |
| AVITA--Aortic Valve Improved Treatment Approaches | Drug | Preclinical | Aortic Stenosis Symptomatic | COMPLETED | NCT04755426 |
| Hemosphere platform® together with the FloTrac® sensor | Other | Approved | Intraoperative Hypotension | COMPLETED | NCT04301102 |
| Hemosphere platform® together with the FloTrac Acumen IQ® sensor | Other | Approved | Intraoperative Hypotension | COMPLETED | NCT04301102 |
| Hemosphere platform® together with the FloTrac® sensor | Other | Approved | Intraoperative Hypotension | COMPLETED | NCT04301102 |
| Hemosphere platform® together with the FloTrac Acumen IQ® sensor | Other | Approved | Intraoperative Hypotension | COMPLETED | NCT04301102 |
| Edwards Cardioband System | Other | Preclinical | Mitral Regurgitation | UNKNOWN | NCT03600688 |
| Edwards Cardioband System | Other | Preclinical | Mitral Regurgitation | UNKNOWN | NCT03600688 |
| Edwards FORMA Tricuspid Transcatheter Repair System | Other | Approved | Tricuspid Valve Regurgitation | COMPLETED | NCT02471807 |
| Transcatheter Tricuspid Valve Repair | Other | Preclinical | Tricuspid Regurgitation | ACTIVE_NOT_RECRUITING | NCT03779490 |
| Transcatheter Tricuspid Valve Repair | Other | Preclinical | Tricuspid Regurgitation | ACTIVE_NOT_RECRUITING | NCT03779490 |
| HPI guided treatment advice | Drug | Approved | Intraoperative Hypotension | COMPLETED | NCT05821647 |
| Treatment of hypotension following standard of care | Drug | Approved | Hypotension During Surgery | UNKNOWN | NCT05844774 |
| HPI (using HemoSphere) - guided algorithm | Other | Approved | Hypotension During Surgery | UNKNOWN | NCT05844774 |
| Mitral surgery alone | Procedure | Approved | Cardiac Surgery | COMPLETED | NCT01246947 |
| Tricuspid valve repair | Other | Approved | Cardiac Surgery | COMPLETED | NCT01246947 |
| Mitral surgery alone | Procedure | Approved | Cardiac Surgery | COMPLETED | NCT01246947 |
| Tricuspid valve repair | Other | Approved | Cardiac Surgery | COMPLETED | NCT01246947 |
| EDWARDS INTUITY valve | Other | Approved | Aortic Valve Stenosis | COMPLETED | NCT01700439 |
| EDWARDS INTUITY valve | Other | Approved | Aortic Valve Stenosis | COMPLETED | NCT01700439 |
| Transcatheter aortic valve replacement | Other | Approved | Aortic Valve Stenosis | UNKNOWN | NCT04160130 |
| transcatheter valve implantation | Other | Preclinical | Aortic Valve Stenosis | COMPLETED | NCT03715894 |
| transcatheter valve implantation | Other | Preclinical | Aortic Valve Stenosis | COMPLETED | NCT03715894 |
| INSPIRIS Resilia (model 11500A) | Other | Preclinical | Heart Valve Prosthesis | RECRUITING | NCT05986396 |
| Aortic Valve Replacement with EDWARDS INTUITY Valve System | Other | Approved | Aortic Valve Stenosis With Insufficiency | COMPLETED | NCT01445171 |
| Aortic Valve Replacement with EDWARDS INTUITY Valve System | Other | Approved | Aortic Valve Stenosis With Insufficiency | COMPLETED | NCT01445171 |
| Aortic Valve Replacement with EDWARDS INTUITY Valve System | Other | Approved | Aortic Valve Stenosis With Insufficiency | COMPLETED | NCT01445171 |
| SAPIEN XT THV with the NovaFlex+ delivery system | Other | Approved | Aortic Stenosis | COMPLETED | NCT03314857 |
| SAPIEN XT THV with the NovaFlex+ delivery system | Other | Approved | Aortic Stenosis | COMPLETED | NCT03314857 |
| SAPIEN XT THV with the NovaFlex+ delivery system | Other | Approved | Aortic Stenosis | COMPLETED | NCT03314857 |
| JUMPSTART exercise program | Other | Preclinical | Aortic Valve Stenosis | UNKNOWN | NCT06040398 |
| Edwards Pericardial Aortic Bioprosthesis Model 11000A | Other | Approved | Pulmonary Valve Insufficiency | COMPLETED | NCT02656290 |
| Edwards Pericardial Aortic Bioprosthesis Model 11000A | Other | Approved | Pulmonary Valve Insufficiency | COMPLETED | NCT02656290 |
| Guideline Directed Medical Therapy | Drug | Approved | Functional Mitral Regurgitation | TERMINATED | NCT03016975 |
| Edwards Cardioband System | Other | Approved | Functional Mitral Regurgitation | TERMINATED | NCT03016975 |
| HPI based hemodynamic optimization algorithm | Other | Approved | Hypotension | COMPLETED | NCT04149314 |
| No intervention | Other | Preclinical | Surgery-Complications | RECRUITING | NCT06166719 |
| No intervention | Other | Preclinical | Surgery-Complications | UNKNOWN | NCT06166719 |
| HARPOON Beating Heart Mitral Valve Repair System (MVRS) | Other | Approved | Mitral Regurgitation | TERMINATED | NCT04382612 |
| HARPOON Beating Heart Mitral Valve Repair System (MVRS) | Other | Approved | Mitral Regurgitation | TERMINATED | NCT04382612 |
| Harpoon Artificial ePTFE Chords | Other | Approved | Mitral Valve Regurgitation | COMPLETED | NCT02768870 |
| Harpoon Artificial ePTFE Chords | Other | Approved | Mitral Valve Regurgitation | COMPLETED | NCT02768870 |
| Harpoon Artificial ePTFE Chords | Other | Approved | Mitral Valve Regurgitation | COMPLETED | NCT02768870 |
| Harpoon Medical Device | Device | Approved | Mitral Valve Regurgitation | COMPLETED | NCT02771275 |
| Harpoon Medical Device | Device | Approved | Mitral Valve Regurgitation | COMPLETED | NCT02771275 |
| Harpoon Medical Device | Device | Approved | Mitral Valve Regurgitation | COMPLETED | NCT02432196 |
| Harpoon Medical Device | Device | Approved | Mitral Valve Regurgitation | COMPLETED | NCT02432196 |
| SAVR Implantation | Other | Approved | Symptomatic Severe Aortic Stenosis | COMPLETED | NCT01314313 |
| TAVR Implantation with SAPIEN XT | Other | Approved | Symptomatic Severe Aortic Stenosis | COMPLETED | NCT01314313 |
| SAVR Implantation | Other | Approved | Symptomatic Severe Aortic Stenosis | COMPLETED | NCT01314313 |
| TAVR Implantation with SAPIEN XT | Other | Approved | Symptomatic Severe Aortic Stenosis | COMPLETED | NCT01314313 |
| SAVR Implantation | Other | Approved | Symptomatic Severe Aortic Stenosis | COMPLETED | NCT01314313 |
| TAVR Implantation with SAPIEN XT | Other | Approved | Symptomatic Severe Aortic Stenosis | COMPLETED | NCT01314313 |
| Computed Tomography, Magnetic Resonance Imaging | Other | Preclinical | CFD | UNKNOWN | NCT06306729 |
| Computed Tomography, Magnetic Resonance Imaging | Other | Preclinical | CFD | NOT_YET_RECRUITING | NCT06306729 |
| Computed Tomography, Magnetic Resonance Imaging | Other | Preclinical | CFD | UNKNOWN | NCT06306729 |
| Non-protocolized Standard of Care | Other | Approved | Moderate to High-risk Noncardiac Surgery | TERMINATED | NCT05105477 |
| AcumenTM HPI Software Feature | Other | Approved | Moderate to High-risk Noncardiac Surgery | TERMINATED | NCT05105477 |
| Non-protocolized Standard of Care | Other | Approved | Moderate to High-risk Noncardiac Surgery | TERMINATED | NCT05105477 |
| AcumenTM HPI Software Feature | Other | Approved | Moderate to High-risk Noncardiac Surgery | TERMINATED | NCT05105477 |
| Subjects previously implanted with a RESILIA aortic tissue valve. | Other | Preclinical | Aortic Valve Replacement | TERMINATED | NCT03680040 |
| Subjects previously implanted with a RESILIA aortic tissue valve. | Other | Preclinical | Aortic Valve Replacement | TERMINATED | NCT03680040 |
| Edwards SAPIEN 3/SAPIEN 3 Ultra THV | Other | Approved | Aortic Stenosis | RECRUITING | NCT03003299 |
| Edwards SAPIEN 3/SAPIEN 3 Ultra THV | Other | Approved | Aortic Stenosis | RECRUITING | NCT03003299 |
| Edwards SAPIEN 3/SAPIEN 3 Ultra THV | Other | Approved | Aortic Stenosis | RECRUITING | NCT03003299 |
| Edwards SAPIEN 3 / SAPIEN 3 Ultra THV | Other | Approved | Heart Diseases | ACTIVE_NOT_RECRUITING | NCT03042104 |
| Edwards PASCAL Transcatheter Valve Repair System | Other | Preclinical | Mitral Valve Insufficiency | COMPLETED | NCT04443218 |
| Edwards EWJ-202 Transcatheter Tricuspid Valve Replacement System | Other | Approved | Tricuspid Valve Regurgitation | ACTIVE_NOT_RECRUITING | NCT05760989 |
| Atrial Shunt | Other | Approved | Heart Failure | WITHDRAWN | NCT04965623 |
| Atrial Shunt | Other | Approved | Heart Failure | WITHDRAWN | NCT04965623 |
| Atrial Shunt | Other | Approved | Heart Failure | WITHDRAWN | NCT04965623 |
| J-Valve Transcatheter Aortic valve replacement | Other | Approved | Aortic Valve Disease | COMPLETED | NCT03025971 |
| J-Valve Transcatheter Aortic valve replacement | Other | Approved | Aortic Valve Disease | COMPLETED | NCT03025971 |
| Transcatheter Aortic Valve Implantation (TAVI) | Other | Approved | Aortic Stenosis | ACTIVE_NOT_RECRUITING | NCT02903420 |
| Education on tailored Quality Improvement measures | Other | Preclinical | Transcatheter Aortic Valve Implantation (TAVI) | COMPLETED | NCT04579445 |
| EV1000A Clinical Platform with Acumen Hypotension Prediction Index Feature Software | Other | Preclinical | Hypotension | COMPLETED | NCT03805217 |
| EV1000A Clinical Platform with Acumen Hypotension Prediction Index Feature Software | Other | Preclinical | Hypotension | COMPLETED | NCT03805217 |
| Transcatheter Tricuspid Valve Replacement | Other | Preclinical | Tricuspid Valve Regurgitation | RECRUITING | NCT06569602 |
| Transcatheter Tricuspid Valve Replacement | Other | Preclinical | Tricuspid Valve Regurgitation | RECRUITING | NCT06569602 |
| Transcatheter Aortic Valve Replacement (TAVR) | Other | Preclinical | Aortic Valve Stenosis | COMPLETED | NCT03699345 |
| Transcatheter Aortic Valve Replacement (TAVR) | Other | Preclinical | Aortic Valve Stenosis | COMPLETED | NCT03699345 |
| Transcatheter Aortic Valve Replacement (TAVR) | Other | Preclinical | Aortic Valve Stenosis | COMPLETED | NCT03699345 |
| EV1000 Clinical Platform with Assisted Fluid Management (AFM) Feature | Other | Approved | Non-Cardiac/ Non-Thoracic Surgery | COMPLETED | NCT03469570 |
| EV1000 Clinical Platform with Assisted Fluid Management (AFM) Feature | Other | Approved | Non-Cardiac/ Non-Thoracic Surgery | COMPLETED | NCT03469570 |
| Hemosphere Advanced Monitoring System, ClearSight 1.5, Swan-Ganz Catheter, Flotrac, Foresight | Other | Preclinical | Pediatric ALL | COMPLETED | NCT04465370 |
| Hemosphere Advanced Monitoring System, ClearSight 1.5, Swan-Ganz Catheter, Flotrac, Foresight | Other | Preclinical | Pediatric ALL | COMPLETED | NCT04465370 |
| Edwards EVOQUE Eos Mitral Valve Replacement System | Other | Approved | Mitral Valve Regurgitation (Degenerative or Functional) | ACTIVE_NOT_RECRUITING | NCT02718001 |
| AcumenTM Hypotension Prediction Index software | Other | Preclinical | Hemodynamic Monitoring | COMPLETED | NCT04972266 |
| AcumenTM Hypotension Prediction Index software | Other | Preclinical | Hemodynamic Monitoring | COMPLETED | NCT04972266 |
| AcumenTM Hypotension Prediction Index software | Other | Preclinical | Hemodynamic Monitoring | COMPLETED | NCT04972266 |
| TAVR | Other | Approved | Symptomatic Severe Aortic Stenosis | COMPLETED | NCT03222128 |
| Transcatheter Aortic Valve Replacement | Other | Preclinical | Aortic Valve Disease | NO_LONGER_AVAILABLE | NCT03876964 |
| Transcatheter Aortic Valve Replacement | Other | Preclinical | Aortic Valve Disease | NO_LONGER_AVAILABLE | NCT03876964 |
| ClearSight baby cuff | Other | Preclinical | Blood Pressure | COMPLETED | NCT06834516 |
| ClearSight baby cuff | Other | Preclinical | Blood Pressure | COMPLETED | NCT06834516 |
| ClearSight baby cuff | Other | Preclinical | Blood Pressure | COMPLETED | NCT06834516 |
| Edwards PASCAL Transcatheter Valve Repair System and Edwards PASCAL Precision Transcatheter Valve Repair System | Other | Preclinical | Mitral Regurgitation | RECRUITING | NCT04430075 |
| APTURE transcatheter shunt | Other | Approved | Heart Failure | ACTIVE_NOT_RECRUITING | NCT04000607 |
| APTURE transcatheter shunt | Other | Approved | Heart Failure | ACTIVE_NOT_RECRUITING | NCT04000607 |
| SAPIEN 3 Ultra System | Other | Preclinical | Aortic Valve Stenosis | ACTIVE_NOT_RECRUITING | NCT04555967 |
| Mitral Valve Replacement (MVR) with Sapien3 | Other | Approved | Mitral Annular Calcification | COMPLETED | NCT02830204 |
| Mitral Valve Replacement (MVR) with Sapien3 | Other | Approved | Mitral Annular Calcification | COMPLETED | NCT02830204 |
| EVOQUE | Other | Preclinical | Tricuspid Regurgitation | RECRUITING | NCT06833476 |
| EVOQUE | Other | Preclinical | Tricuspid Regurgitation | RECRUITING | NCT06833476 |
| Hypotension probability index (HPI) | Other | Approved | Hypotension | COMPLETED | NCT04151264 |
| GDT-based hemodynamic management based on Clearsight device | Device | Approved | Intraoperative Hypotension | RECRUITING | NCT06291714 |
| GDT-based hemodynamic management based on Clearsight device | Device | Approved | Intraoperative Hypotension | RECRUITING | NCT06291714 |
| SAPIEN 3 Ultra System | Other | Preclinical | Aortic Valve Stenosis | ACTIVE_NOT_RECRUITING | NCT04555967 |
| Innovalve MR system | Other | Approved | Mitral Valve Regurgitation (Degenerative or Functional) | COMPLETED | NCT05688514 |
| Innovalve MR system | Other | Approved | Mitral Valve Regurgitation (Degenerative or Functional) | COMPLETED | NCT05682066 |
| Innovalve MR system | Other | Approved | Mitral Valve Regurgitation (Degenerative or Functional) | COMPLETED | NCT05682066 |
| CEP MAGNA MITRAL PERICARDIAL BIOPROSTHESES | Other | Approved | Coronary Artery Disease | COMPLETED | NCT00853632 |
| CEP MAGNA MITRAL PERICARDIAL BIOPROSTHESES | Other | Approved | Coronary Artery Disease | COMPLETED | NCT00853632 |
| SAPIEN 3 Ultra Delivery System with the SAPIEN 3 Ultra THV | Other | Approved | Aortic Valve Stenosis | COMPLETED | NCT03471065 |
| Magna Ease | Other | Preclinical | Mitral Valve or Aortic Valve Replacement | TERMINATED | NCT02523066 |
| INSPIRIS RESILIA Aortic Valve™ | Other | Preclinical | Cardiovascular Diseases | ACTIVE_NOT_RECRUITING | NCT04053088 |
| INSPIRIS RESILIA Aortic Valve™ | Other | Preclinical | Cardiovascular Diseases | ACTIVE_NOT_RECRUITING | NCT04053088 |
| AVR with or without CABG | Other | Preclinical | Aortic Valve Stenosis | ACTIVE_NOT_RECRUITING | NCT03666741 |
| AVR with or without CABG | Other | Preclinical | Aortic Valve Stenosis | ACTIVE_NOT_RECRUITING | NCT03666741 |
| AVR with or without CABG | Other | Preclinical | Aortic Valve Stenosis | ACTIVE_NOT_RECRUITING | NCT03666741 |
| Early discharge protocol | Other | Preclinical | Mitral Regurgitation | COMPLETED | NCT06343363 |
| Early discharge protocol | Other | Preclinical | Mitral Regurgitation | COMPLETED | NCT06343363 |
| Non-protocolized Standard of Care | Other | Approved | Cardiopulmonary Bypass Surgery | ACTIVE_NOT_RECRUITING | NCT05083403 |
| AcumenTM HPI Software Feature | Other | Approved | Cardiopulmonary Bypass Surgery | ACTIVE_NOT_RECRUITING | NCT05083403 |
| Non-protocolized Standard of Care | Other | Approved | Cardiopulmonary Bypass Surgery | ACTIVE_NOT_RECRUITING | NCT05083403 |
| AcumenTM HPI Software Feature | Other | Approved | Cardiopulmonary Bypass Surgery | ACTIVE_NOT_RECRUITING | NCT05083403 |
| Innovalve TMVR system | Other | Approved | Mitral Valve Regurgitation (Degenerative or Functional) | ACTIVE_NOT_RECRUITING | NCT05010746 |
| Edwards PASCAL Transcatheter Valve Repair System and Edwards PASCAL Precision Transcatheter Valve Repair System | Other | Preclinical | Mitral Regurgitation | RECRUITING | NCT04430075 |
| Edwards PASCAL Precision Transcatheter Valve Repair System | Other | Preclinical | Tricuspid Valve Insufficiency | ACTIVE_NOT_RECRUITING | NCT04614402 |
| Edwards PASCAL Transcatheter Valve Repair System | Other | Preclinical | Tricuspid Valve Insufficiency | ACTIVE_NOT_RECRUITING | NCT04614402 |
| Edwards PASCAL Precision Transcatheter Valve Repair System | Other | Preclinical | Tricuspid Valve Insufficiency | ACTIVE_NOT_RECRUITING | NCT04614402 |
| Edwards PASCAL Transcatheter Valve Repair System | Other | Preclinical | Tricuspid Valve Insufficiency | ACTIVE_NOT_RECRUITING | NCT04614402 |
| Edwards PASCAL Precision Transcatheter Valve Repair System | Other | Preclinical | Tricuspid Valve Insufficiency | ACTIVE_NOT_RECRUITING | NCT04614402 |
| Edwards PASCAL Transcatheter Valve Repair System | Other | Preclinical | Tricuspid Valve Insufficiency | ACTIVE_NOT_RECRUITING | NCT04614402 |
| J-Valve TF System | Other | Approved | Aortic Valve Disease | ACTIVE_NOT_RECRUITING | NCT06034028 |
| J-Valve TF System | Other | Approved | Aortic Valve Disease | ACTIVE_NOT_RECRUITING | NCT06034028 |
| HemoSphere Advanced Monitoring Platform with Acumen IQ sensor and Tissue Oximetry Monitoring | Other | Approved | Blood Pressure | RECRUITING | NCT06492746 |
| HemoSphere Advanced Monitoring Platform with Acumen IQ sensor and Tissue Oximetry Monitoring | Other | Approved | Blood Pressure | RECRUITING | NCT06492746 |
| Edwards SAPIEN M3 System | Other | Approved | Mitral Regurgitation | ACTIVE_NOT_RECRUITING | NCT03230747 |
| Edwards SAPIEN M3 System | Other | Approved | Mitral Regurgitation | ACTIVE_NOT_RECRUITING | NCT03230747 |
| Standardized Invasive Hemodynamics | Other | Preclinical | Aortic Stenosis | COMPLETED | NCT04827238 |
| Transcatheter Aortic Valve Implantation (TAVI) | Other | Preclinical | Aortic Stenosis | COMPLETED | NCT04860752 |
| Transcatheter Aortic Valve Implantation (TAVI) | Other | Preclinical | Aortic Stenosis | COMPLETED | NCT04860752 |
| SAPIEN 3 Transcatheter Heart Valve | Other | Preclinical | Aortic Stenosis, Severe | ACTIVE_NOT_RECRUITING | NCT05168826 |
| SAPIEN 3 Transcatheter Heart Valve | Other | Preclinical | Aortic Stenosis, Severe | ACTIVE_NOT_RECRUITING | NCT05168826 |
| SAPIEN 3 Transcatheter Heart Valve | Other | Preclinical | Aortic Stenosis, Severe | ACTIVE_NOT_RECRUITING | NCT05168826 |
| SAPIEN X4 THV | Other | Approved | Aortic Stenosis, Severe | ACTIVE_NOT_RECRUITING | NCT05172960 |
| Elective redo transcatheter aortic valve implantation (redo-TAVI) | Other | Preclinical | Structural Valve Deterioration | RECRUITING | NCT05601453 |
| Elective redo transcatheter aortic valve implantation (redo-TAVI) | Other | Preclinical | Structural Valve Deterioration | RECRUITING | NCT05601453 |
| HARPOON™ Beating Heart Mitral Valve Repair System | Other | Approved | Mitral Regurgitation | ACTIVE_NOT_RECRUITING | NCT04375332 |
| HARPOON™ Beating Heart Mitral Valve Repair System | Other | Approved | Mitral Regurgitation | ACTIVE_NOT_RECRUITING | NCT04375332 |
| Virtual Reality assisted information | Other | Approved | Severe Aortic Valve Stenosis | RECRUITING | NCT05552352 |
| Virtual Reality assisted information | Other | Approved | Severe Aortic Valve Stenosis | RECRUITING | NCT05552352 |
| Subjects previously implanted with INSPIRIS RESILIA Model 11500A and are undergoing planned valve-in-valve treatment. | Drug | Preclinical | Aortic Valve Replacement | SUSPENDED | NCT04902053 |
| Subjects previously implanted with INSPIRIS RESILIA Model 11500A and are undergoing planned valve-in-valve treatment. | Drug | Preclinical | Aortic Valve Replacement | SUSPENDED | NCT04902053 |
| SAPIEN 3 THV with the Commander delivery system | Other | Approved | Aortic Stenosis | COMPLETED | NCT03466918 |
| SAPIEN 3 THV with the Commander delivery system | Other | Approved | Aortic Stenosis | COMPLETED | NCT03466918 |
| Transcatheter Atrial Shunt System | Other | Approved | Heart Failure | ACTIVE_NOT_RECRUITING | NCT03523416 |
| Transcatheter Atrial Shunt System | Other | Approved | Heart Failure | ACTIVE_NOT_RECRUITING | NCT03523416 |
| Edwards Alterra Adaptive Prestent with SAPIEN 3 THV | Other | Approved | Pulmonary Disease | ACTIVE_NOT_RECRUITING | NCT03130777 |
| Edwards PASCAL Transcatheter Valve Repair System | Other | Approved | Tricuspid Regurgitation | COMPLETED | NCT03745313 |
| Edwards PASCAL Transcatheter Valve Repair System | Other | Approved | Tricuspid Regurgitation | COMPLETED | NCT03745313 |
| Edwards PASCAL Transcatheter Valve Repair System | Other | Approved | Tricuspid Regurgitation | COMPLETED | NCT03745313 |
| TAVI | Other | Approved | Aortic Valve Stenosis | COMPLETED | NCT02729519 |
| TAVI | Other | Approved | Aortic Valve Stenosis | COMPLETED | NCT02729519 |
| Transcatheter Tricuspid Valve Repair | Other | Approved | Tricuspid Regurgitation | ACTIVE_NOT_RECRUITING | NCT03382457 |
| Transcatheter Tricuspid Valve Repair | Other | Approved | Tricuspid Regurgitation | ACTIVE_NOT_RECRUITING | NCT03382457 |
| HemoSphere Vita Monitor, VitaWave or VitaWave Plus Finger Cuff Adult, ForeSight Large Sensors | Other | Approved | Blood Pressure | NOT_YET_RECRUITING | NCT07216573 |
| MITRIS RESILIA Mitral Valve, Model 11400M | Other | Preclinical | Mitral Stenosis | ACTIVE_NOT_RECRUITING | NCT05526560 |
| Standard of Care Blood Pressure Monitoring | Other | Approved | Anesthesia, Epidural | COMPLETED | NCT05906368 |
| ClearSight HPI Monitoring system | Other | Approved | Anesthesia, Epidural | COMPLETED | NCT05906368 |
| Standard of Care Blood Pressure Monitoring | Other | Approved | Anesthesia, Epidural | COMPLETED | NCT05906368 |
| ClearSight HPI Monitoring system | Other | Approved | Anesthesia, Epidural | COMPLETED | NCT05906368 |
| Standard of Care Blood Pressure Monitoring | Other | Approved | Anesthesia, Epidural | COMPLETED | NCT05906368 |
| ClearSight HPI Monitoring system | Other | Approved | Anesthesia, Epidural | COMPLETED | NCT05906368 |
| Edwards Alterra Adaptive Prestent with SAPIEN 3 Transcatheter Pulmonary Valve System | Other | Preclinical | Pulmonary Valve Insufficiency | ACTIVE_NOT_RECRUITING | NCT05378386 |
| Edwards Alterra Adaptive Prestent with SAPIEN 3 Transcatheter Pulmonary Valve System | Other | Preclinical | Pulmonary Valve Insufficiency | ACTIVE_NOT_RECRUITING | NCT05378386 |
| Edwards SAPIEN 3 transcatheter valve, Model 9600TFX | Other | Approved | Mitral Valve Insufficiency | ACTIVE_NOT_RECRUITING | NCT03193801 |
| Edwards SAPIEN 3 transcatheter valve, Model 9600TFX | Other | Approved | Mitral Valve Insufficiency | ACTIVE_NOT_RECRUITING | NCT03193801 |
| HemoSphere Alta Monitor, Swan-Ganz IQ pulmonary arterial catheter, ForeSight IQ Large sensor, and Acumen IQ sensor | Other | Preclinical | Hemodynamic Instability | RECRUITING | NCT07148323 |
| HemoSphere Alta Monitor, Swan-Ganz IQ pulmonary arterial catheter, ForeSight IQ Large sensor, and Acumen IQ sensor | Other | Preclinical | Hemodynamic Instability | RECRUITING | NCT07148323 |
| TAVR with CENTERA THV | Other | Approved | Aortic Valve Stenosis | ACTIVE_NOT_RECRUITING | NCT03517436 |
| TAVR with CENTERA THV | Other | Approved | Aortic Valve Stenosis | ACTIVE_NOT_RECRUITING | NCT03517436 |
| Edwards Aortic and Mitral Bioprostheses Models 11000A and 11000M | Other | Approved | Aortic Stenosis | ACTIVE_NOT_RECRUITING | NCT01757665 |
| Edwards Aortic and Mitral Bioprostheses Models 11000A and 11000M | Other | Approved | Aortic Stenosis | ACTIVE_NOT_RECRUITING | NCT01757665 |
| The ABC Bicuspid Sizing Algorithm | Other | Preclinical | Aortic Stenosis | RECRUITING | NCT06991517 |
| The ABC Bicuspid Sizing Algorithm | Other | Preclinical | Aortic Stenosis | RECRUITING | NCT06991517 |
| The ABC Bicuspid Sizing Algorithm | Other | Preclinical | Aortic Stenosis | RECRUITING | NCT06991517 |
| SAPIEN XT THV | Other | Preclinical | Pulmonary Valve Insufficiency | COMPLETED | NCT02987387 |
| SAPIEN 3 / SAPIEN 3 Ultra / SAPIEN 3 Ultra RESILIA | Other | Approved | Aortic Stenosis, Calcific | RECRUITING | NCT04889872 |
| SAPIEN 3 / SAPIEN 3 Ultra / SAPIEN 3 Ultra RESILIA | Other | Approved | Aortic Stenosis, Calcific | RECRUITING | NCT04889872 |
| SAPIEN X4 THV | Other | Approved | Mitral Regurgitation | NOT_YET_RECRUITING | NCT06167213 |
| SAPIEN X4 THV | Other | Approved | Mitral Regurgitation | NOT_YET_RECRUITING | NCT06167213 |
| SAPIEN X4 THV | Other | Approved | Mitral Regurgitation | NOT_YET_RECRUITING | NCT06167213 |
| The HemoSphere advanced monitoring platform with Acumen HPI software, and Acumen IQ sensor and Acumen IQ cuff | Other | Approved | Moderate to High-risk Noncardiac Surgery | COMPLETED | NCT05957406 |
| Acumen HPI Smart Alerts and Smart Trends Software | Other | Approved | Moderate to High-risk Noncardiac Surgery | COMPLETED | NCT05957406 |
| The HemoSphere advanced monitoring platform with Acumen HPI software, and Acumen IQ sensor and Acumen IQ cuff | Other | Approved | Moderate to High-risk Noncardiac Surgery | COMPLETED | NCT05957406 |
| Acumen HPI Smart Alerts and Smart Trends Software | Other | Approved | Moderate to High-risk Noncardiac Surgery | COMPLETED | NCT05957406 |
| SAPIEN X4 THV | Other | Approved | Aortic Valve Insufficiency | RECRUITING | NCT05172973 |
| SAPIEN X4 THV | Other | Approved | Aortic Valve Insufficiency | RECRUITING | NCT05172973 |
| MITRIS RESILIA Mitral Valve | Other | Preclinical | Mitral Valve Replacement | RECRUITING | NCT07059793 |
| MITRIS RESILIA Mitral Valve | Other | Preclinical | Mitral Valve Replacement | RECRUITING | NCT07059793 |
| Transcatheter Tricuspid Valve Replacement | Other | Approved | Tricuspid Valve Regurgitation | ACTIVE_NOT_RECRUITING | NCT04221490 |
| SAPIEN 3 THV | Other | Approved | Aortic Stenosis | ACTIVE_NOT_RECRUITING | NCT02675114 |
| SAVR | Other | Approved | Aortic Stenosis | ACTIVE_NOT_RECRUITING | NCT02675114 |
| APTURE transcatheter shunt | Other | Approved | Heart Failure | ACTIVE_NOT_RECRUITING | NCT04000607 |
| INNOVALVE system | Other | Approved | Mitral Valve Regurgitation (Degenerative or Functional) | RECRUITING | NCT04919980 |
| INNOVALVE system | Other | Approved | Mitral Valve Regurgitation (Degenerative or Functional) | RECRUITING | NCT04919980 |
| INNOVALVE system | Other | Approved | Mitral Valve Regurgitation (Degenerative or Functional) | RECRUITING | NCT04919980 |
| SAPIEN 3 THV | Other | Preclinical | Complex Congenital Heart Defect | ACTIVE_NOT_RECRUITING | NCT04860765 |
| Mitral Valve Repair | Other | Approved | Mitral Valve Regurgitation | COMPLETED | NCT03170349 |
| Mitral Valve Repair | Other | Approved | Mitral Valve Regurgitation | COMPLETED | NCT03170349 |
| Abbott Mitraclip System | Other | Approved | Degenerative Mitral Valve Disease | ACTIVE_NOT_RECRUITING | NCT03706833 |
| Edwards PASCAL System | Other | Approved | Degenerative Mitral Valve Disease | ACTIVE_NOT_RECRUITING | NCT03706833 |
| 'Double tap' balloon post-dilation | Other | Approved | Aortic Stenosis | NOT_YET_RECRUITING | NCT07430267 |
| 'Double tap' balloon post-dilation | Other | Approved | Aortic Stenosis | NOT_YET_RECRUITING | NCT07430267 |
| 'Double tap' balloon post-dilation | Other | Approved | Aortic Stenosis | NOT_YET_RECRUITING | NCT07430267 |
| SAPIEN M3 valve and dock | Other | Approved | Mitral Regurgitation | RECRUITING | NCT04153292 |
| SAPIEN M3 valve and dock | Other | Approved | Mitral Regurgitation | RECRUITING | NCT04153292 |
| SAPIEN M3 valve and dock | Other | Approved | Mitral Regurgitation | RECRUITING | NCT04153292 |
| Optimal Medical Therapy | Drug | Approved | Tricuspid Valve Regurgitation | ACTIVE_NOT_RECRUITING | NCT04482062 |
| Edwards EVOQUE System | Other | Approved | Tricuspid Valve Regurgitation | ACTIVE_NOT_RECRUITING | NCT04482062 |
| J-Valve Transfemoral System | Other | Approved | Aortic Valve Regurgitation | NOT_YET_RECRUITING | NCT07363473 |
| J-Valve Transfemoral System | Other | Approved | Aortic Valve Regurgitation | NOT_YET_RECRUITING | NCT07363473 |
| J-Valve Transfemoral System | Other | Approved | Aortic Valve Regurgitation | NOT_YET_RECRUITING | NCT07363473 |
| J-Valve Transfemoral System | Other | Approved | Aortic Valve Regurgitation | NOT_YET_RECRUITING | NCT07363473 |
| SAPIEN 3 Ultra RESILIA THV | Other | Approved | Complex Congenital Heart Defect | RECRUITING | NCT02744677 |
| SAPIEN 3 THV | Other | Approved | Complex Congenital Heart Defect | RECRUITING | NCT02744677 |
| SAPIEN 3/SAPIEN 3 Ultra RESILIA THV | Other | Approved | Complex Congenital Heart Defect | RECRUITING | NCT02744677 |
| Sham procedure | Procedure | Approved | Heart Failure | ACTIVE_NOT_RECRUITING | NCT05686317 |
| Edwards APTURE transcatheter shunt system | Other | Approved | Heart Failure | ACTIVE_NOT_RECRUITING | NCT05686317 |
| Sham procedure | Procedure | Approved | Heart Failure | ACTIVE_NOT_RECRUITING | NCT05686317 |
| Edwards APTURE transcatheter shunt system | Other | Approved | Heart Failure | ACTIVE_NOT_RECRUITING | NCT05686317 |
| Sham procedure | Procedure | Approved | Heart Failure | ACTIVE_NOT_RECRUITING | NCT05686317 |
| Edwards APTURE transcatheter shunt system | Other | Approved | Heart Failure | ACTIVE_NOT_RECRUITING | NCT05686317 |
| - Non-Invasive Near-infrared Spectroscopy (NIRS) device (HEM1 with Foresight Elite Sensor) | Device | Preclinical | Subarachnoid Hemorrhage, Aneurysmal | NOT_YET_RECRUITING | NCT06932640 |
| - Non-Invasive Near-infrared Spectroscopy (NIRS) device (HEM1 with Foresight Elite Sensor) | Device | Preclinical | Subarachnoid Hemorrhage, Aneurysmal | NOT_YET_RECRUITING | NCT06932640 |
| J-Valve Transfemoral (TF) System | Other | Approved | Aortic Valve Regurgitation | RECRUITING | NCT06455787 |
| J-Valve Transfemoral (TF) System | Other | Approved | Aortic Valve Regurgitation | RECRUITING | NCT06455787 |
| EDWARDS INSPIRIS RESILIA Aortic Valve | Other | Preclinical | Aortic Valve Replacement | ACTIVE_NOT_RECRUITING | NCT05404880 |
| EDWARDS INSPIRIS RESILIA Aortic Valve | Other | Preclinical | Aortic Valve Replacement | ACTIVE_NOT_RECRUITING | NCT05404880 |
| EDWARDS INSPIRIS RESILIA Aortic Valve | Other | Preclinical | Aortic Valve Replacement | ACTIVE_NOT_RECRUITING | NCT05404880 |
| Streamlining of the pre-procedural patient pathway | Other | Preclinical | Transcatheter Aortic Valve Implantation (TAVI) | COMPLETED | NCT05750173 |
| Edwards INSPIRIS RESILIA Aortic Valve | Other | Preclinical | Aortic Valve Disease | RECRUITING | NCT07120048 |
| Edwards INSPIRIS RESILIA Aortic Valve | Other | Preclinical | Aortic Valve Disease | RECRUITING | NCT07120048 |
| Edwards INSPIRIS RESILIA Aortic Valve | Other | Preclinical | Aortic Valve Disease | RECRUITING | NCT07120048 |
| Optimal Medical Therapy | Drug | Approved | Tricuspid Regurgitation | RECRUITING | NCT04097145 |
| Edwards PASCAL System | Other | Approved | Tricuspid Regurgitation | RECRUITING | NCT04097145 |
| Optimal Medical Therapy | Drug | Approved | Tricuspid Regurgitation | RECRUITING | NCT04097145 |
| Edwards PASCAL System | Other | Approved | Tricuspid Regurgitation | RECRUITING | NCT04097145 |
| Optimal Medical Therapy | Drug | Approved | Tricuspid Regurgitation | RECRUITING | NCT04097145 |
| Edwards PASCAL System | Other | Approved | Tricuspid Regurgitation | RECRUITING | NCT04097145 |
| ClearSight NextGen system | Other | Approved | Blood Pressure | COMPLETED | NCT07317648 |
| ClearSight NextGen system | Other | Approved | Blood Pressure | COMPLETED | NCT07317648 |
| ClearSight NextGen system | Other | Approved | Blood Pressure | COMPLETED | NCT07317648 |
| Edwards EVOQUE Eos Mitral Valve Replacement System | Other | Approved | Mitral Valve Regurgitation (Degenerative or Functional) | ACTIVE_NOT_RECRUITING | NCT02718001 |
| Edwards EVOQUE Eos Mitral Valve Replacement System | Other | Approved | Mitral Valve Regurgitation (Degenerative or Functional) | ACTIVE_NOT_RECRUITING | NCT02718001 |
| MITRIS RESILIA Mitral Valve, Model 11400M | Other | Preclinical | Mitral Stenosis | ACTIVE_NOT_RECRUITING | NCT05526560 |
| HemoSphere Vita Monitor with VitaWave or VitaWave Plus Finger Cuff Adult, and ForeSight Large Sensors | Other | Approved | Blood Pressure | RECRUITING | NCT07216573 |
| HemoSphere Vita Monitor with VitaWave or VitaWave Plus Finger Cuff Adult, and ForeSight Large Sensors | Other | Approved | Blood Pressure | RECRUITING | NCT07216573 |